Next Article in Journal
Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection
Next Article in Special Issue
Bioguided Optimization of the Nutrition-Health, Antioxidant, and Immunomodulatory Properties of Manihot esculenta (Cassava) Flour Enriched with Cassava Leaves
Previous Article in Journal
Associations between Celiac Disease, Extra-Gastrointestinal Manifestations, and Gluten-Free Diet: A Narrative Overview
Previous Article in Special Issue
Traditional Uses, Phytochemistry, and Pharmacological Activities of Vernonia cinerea (L.) Less.: An Updated Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants

1
Biology Department, Université de Moncton, Moncton, NB E1A 3E9, Canada
2
Chemistry and Biochemistry Department, Université de Moncton, Moncton, NB E1A 3E9, Canada
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(12), 1815; https://doi.org/10.3390/nu16121815
Submission received: 1 May 2024 / Revised: 5 June 2024 / Accepted: 7 June 2024 / Published: 9 June 2024
(This article belongs to the Special Issue The Benefits of Natural Products for Disease Treatments)

Abstract

:
Androgen production primarily occurs in Leydig cells located in the interstitial compartment of the testis. In aging males, testosterone is crucial for maintaining muscle mass and strength, bone density, sexual function, metabolic health, energy levels, cognitive function, as well as overall well-being. As men age, testosterone production by Leydig cells of the testes begins to decline at a rate of approximately 1% per year starting from their 30s. This review highlights recent findings concerning the use of natural polyphenolics compounds, such as flavonoids, resveratrol, and phenolic acids, to enhance testosterone production, thereby preventing age-related degenerative conditions associated with testosterone insufficiency. Interestingly, most of the natural polyphenolic antioxidants having beneficial effects on testosterone production tend to enhance the expression of the steroidogenic acute regulatory protein (Star) gene in Leydig cells. The STAR protein facilitates the entry of the steroid precursor cholesterol inside mitochondria, a rate-limiting step for androgen biosynthesis. Natural polyphenolic compounds can also improve the activities of steroidogenic enzymes, hypothalamus-pituitary gland axis signaling, and testosterone bioavailability. Thus, many polyphenolic compounds such as luteolin, quercetin, resveratrol, ferulic acid phenethyl ester or gigantol may be promising in delaying the initiation of late-onset hypogonadism accompanying aging in males.

1. Introduction

Androgens are mainly produced by testis Leydig cells in vertebrates. These steroid hormones are essential for the development, as well as the maintenance, of male sex organs and secondary sexual characteristics. In the embryo, testosterone stimulates the development of Wolff’s ducts, which will differentiate into the epididymis, vas deferens and seminal vesicles. In addition, testosterone is converted into dihydrotestosterone (DHT) to stimulate the development of the penis, scrotum and prostate from the genital tubercle. At puberty, testosterone is responsible for masculinization of the central nervous system, initiation and maintenance of spermatogenesis, differentiation of external genitalia, hair growth, bone growth, and regulation of the secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In the seminiferous tubules of the testis, androgens interact with the androgen-binding protein (ABP, SHBG) in Sertoli cells, supporting the division of germ cells and normal spermatogenesis. Male hypogonadism is characterized by lower-than-normal production of testosterone by the testes, which may result in decreased sperm production. From their thirties, testosterone production by Leydig cells in the testis declines at a rate of 1% per year in men [1]. This decline in serum testosterone levels, contributing to the development of late-onset hypogonadism, is accentuated by a variety of conditions, including exposure to endocrine disruptors, metabolic disorders, and cancer treatments [2]. With aging, Leydig cells respond less effectively to the pituitary hormone LH to stimulate androgen production [3]. Men with lower-than-normal serum levels of androgen may experience decreased libido, erectile dysfunction, reduced body hair, decreased muscle mass, low bone mineral density, increased body fat, increased fatigue, irritability, difficulty to concentrate, as well as poor overall quality of life [4,5]. Therefore, therapies aimed at restoring serum testosterone levels to normal, including nutritional supplementation with polyphenolic compounds, may alleviate some of these symptoms. In this review, the structure-activity relationship of plant-derived polyphenolic compounds on androgen production will be considered as a potential approach to limit the development of male late-onset hypogonadism.
The literature search methodology for this review consisted in searching for scientific publications found in the bibliographic databases NCBI-PubMed and Google Scholar using the following keywords: (Natural antioxidant OR Flavonoid OR Phenolic OR Polyphenol OR Polyphenolic) AND (Testosterone OR Androgen OR Leydig), with no limitations on date of publication. All relevant scientific works identified as suitable for this topic were included in this review. This literature review will focus on natural polyphenol antioxidants because of their potential to enhance the steroidogenic capacity of Leydig cells, as demonstrated by our laboratory research [6,7,8,9,10]. In addition, polyphenolic compounds have anti-aging properties such as the capacity to inhibit apoptosis caused by reactive oxygen species, and the ability to increase the activity of oxidative stress-limiting enzymes like superoxide dismutase, glutathione peroxidase and catalase [11,12]. Moreover, flavonoids such as quercetin may prevent aging-related diseases by targeting the NAD+-dependent deacetylase enzyme sirtuin involved in the regulation of cellular senescence and multiple aging-related cellular processes [13]. In Leydig cells, sirtuin may serve as an interesting target to restore mitochondrial dysfunction and enhance steroid production.

2. Testosterone Synthesis by Leydig Cells

In the testis, the biosynthesis of testosterone occurs in Leydig cells. Androstenedione and dehydroepiandrosterone (DHEA) are also produced; however, their efficacy to activate the androgen receptor is lower than testosterone. Adult Leydig cells also contain the aromatase enzyme (CYP19A1) involved in the transformation of androgen into estrogen [14]. However, such rate of conversion of testosterone into estradiol is relatively minimal, and estrogen may rather moderate steroid production by Leydig cells [15]. The biosynthesis of testosterone relies on the steroidogenic enzymes cholesterol side chain cleavage enzyme (CYP11A1), cytochrome P450 17α-hydroxylase/20-lyase (CYP17A1), 3β-hydroxysteroid dehydrogenase (HSD3B2 in humans and HSD3B1 in rodents) and 17β-hydroxysteroid dehydrogenase type 3 (HSD17B3) with cholesterol as the initial substrate (Figure 1). Cholesterol can be produced from acetyl CoA or obtained from plasma using receptor mediated endocytosis of LDL particles. Cholesterol can be stored as an esterified form in lipid droplets in the cytoplasm of Leydig cells. These cells depend primarily on endogenous cholesterol synthesis for testosterone biosynthesis under normal physiological conditions. However, the increased demand for cholesterol can be satisfied by increased uptake of extracellular cholesterol from LDL and HDL via endocytosis mediated by the surface receptors LDLR and scavenger receptor class B, type I (SCARB1) [16].
The initial reaction in steroid production requires the translocation of cytoplasmic cholesterol inside mitochondria. This is initiated by the assembly of a carrier protein complex, including the steroidogenic acute regulatory protein (STAR) and the translocator protein (TSPO), at the outer mitochondrial membrane [17,18]. Inside mitochondria, cholesterol is metabolized to pregnenolone by the CYP11A1 enzyme with the implication of the electron carrier ferredoxin and the electron donor NADPH: ferredoxin reductase [19]. Once produced, pregnenolone leaves the mitochondria and enters the smooth endoplasmic reticulum (SER) by diffusion to complete testosterone synthesis with the HSD3B, CYP17A1 and HSD17B3 enzymes. Testosterone is a critical endocrine and paracrine steroid hormone initiating and maintaining spermatogenesis in the testes, and male secondary sexual characteristics. During aging, STAR protein levels are reduced in adult Leydig cells, leading to a reduction in mitochondrial cholesterol import and a decline in androgen production [20,21]. This age-related decline in the production of testosterone can be delayed by maintaining expression of the Star and/or Cyp11a1 genes with the aid of polyphenolic antioxidant supplementation [22,23].
The hormone LH activates the expression of genes encoding steroidogenic enzymes via activation of the cAMP/protein kinase A (PKA) signaling pathway in Leydig cells. PKA substrates include STAR, responsible for cholesterol transport within the mitochondria, and several transcription factors essential for regulating steroidogenic gene expression. In addition to the cAMP/PKA pathway, other signaling pathways such as mitogen activated protein kinases (MAPK), protein kinase C (PKC), Ca2+-calmodulin dependent protein kinases (CAMK) and Janus kinases/signal transducer and activator of transcription proteins (JAK/STAT) regulate steroidogenesis in testis Leydig cells. Indeed, activation of the epidermal growth factor receptor (EGFR) regulates steroidogenesis by modulating the activity of the extracellular signal-regulated kinases (ERK1/2) component of MAPK signaling [24,25]. The adipose derived hormones leptin and resistin regulate steroidogenesis through the activation of JAK/STAT pathway in Leydig cells [26,27]. Increased intracellular Ca2+ levels lead to accumulation of calmodulin-associated Ca2+ and activation of Ca2+/calmodulin kinase kinase (CAMKK). The latter specifically phosphorylates and activates Ca2+/calmodulin kinase I (CAMKI) in adult Leydig cells, playing an important role in regulating Star gene expression [28]. Activation of both PKC and PKA contributes to the upregulation of STAR and steroidogenesis in Leydig cells [29,30]. Nutrients, such as plant polyphenolic compounds, can promote testosterone production in Leydig cells via various regulatory mechanisms, including modulation of intracellular signal transduction pathways, and these actions may depend on a specific structure-function relationship.

3. Development of Late-Onset Male Hypogonadism

Late-onset male hypogonadism is characterized by a decline in testosterone production in the testes as a function of aging. This condition is usually treated with testosterone replacement therapy, leading to undesirable side effects. For instance, spermatogenesis is dramatically reduced, leading to decreased fertility [31]. This results from negative feedback by exogenous testosterone on the hypothalamus and pituitary, resulting in decreased secretion of the gonadotropin releasing hormone (GnRH), as well as of FSH and LH.
Testosterone plays several important roles in aging males by maintaining muscle mass and strength, bone density, sexual function, energy level, metabolic health, cognitive function, and overall well-being (Table 1). As men age and testosterone levels decline, they may experience a gradual loss of muscle mass and strength, known as sarcopenia [32]. Low testosterone levels in aging males can lead to a decrease in bone mineral density, increasing the risk of osteoporosis and fractures [33]. Declining testosterone levels can result in reduced sexual desire, erectile dysfunction, and other sexual problems [34]. Low testosterone levels in aging males may contribute to feelings of fatigue, decreased motivation, and reduced energy levels [35]. Testosterone has an impact on metabolism, including the regulation of fat distribution, insulin sensitivity, and glucose metabolism (Table 1) [36]. Hence, low testosterone levels may contribute to an increased risk of obesity, metabolic syndrome, and type 2 diabetes in aging males [37]. Although not clearly established, some research suggests that testosterone may have a positive effect on cognitive function, such as memory and concentration [38,39]. Hence, low testosterone levels have been associated with cognitive decline [40], increased risk of Alzheimer’s disease [41], and symptoms of depression [42].
Thus, maintaining adequate testosterone levels is important for various aspects of health and well-being in aging males. Natural antioxidants such as polyphenolic compounds from fruits and vegetables may promote optimal testosterone production and delay symptoms associated with late-onset hypogonadism in aging males.

4. Natural Antioxidants Contributing to the Optimal Production of Androgen

4.1. Flavonoids

Flavonoids are of vital and crucial importance to many plants, and they are found in various parts of the plant. These constituents play an important role in the development of plants, as well as in their defense against pathogens [66]. Flavonoids’ basic skeleton is characterized by two benzene rings linked by a three-carbon segment. The different types of flavonoids can be distinguished by the oxygenated heterocycle (ring C) created by the three-carbon segment, its oxidation level, and the hydroxyl groups (-OH) of ring A (see Figure 2 for the structures of important flavonoids found in plants).
Flavonoids can be divided into flavanone, flavones, flavonols and anthocyanidins, based on distinctions in the 2-phenyl-3,4-dihydro-2H-1-benzopyran backbone [67]. Isoflavonoids can be classified in two main families: isoflavans and isoflavones, both with a 3-phenyl-3,4-dihydro-2H-1-benzopyran backbone [67]. The presence of oxygen, either with hydroxyls or ketones, reduces the lipophilicity of the molecules while increasing the possibility of hydrogen bonds formation (Table 2). The biological effect of these molecules may be partly due to their solubility, but largely to the presence of specific receptors or favorable interactions between the molecule and its target. Prenylated flavonoids are an excellent example of increased lipophilicity leading to greater affinity with the cell membranes [68].
Since they were first characterized, flavonoids have been associated with a number of health benefits, including cancer prevention, reducing the risk of cardiovascular and neurodegenerative diseases, and delaying age-related symptoms (reviewed in [70]). Since the early 60s, over 900 publications have reported on the actions of various flavonoids on androgen production. However, the molecular mechanisms by which flavonoids regulate steroid biosynthesis remain to be better defined.

4.1.1. Flavones

Flavones are characterized by the presence of a ketone moiety and a double bond in the ring C (Figure 1). Luteolin and apigenin are flavones found in celery, thyme and parsley. Interestingly, we found that chrysin, apigenin, luteolin and baicalein can stimulate the cAMP-dependent expression of Star, Cyp11a1 and Fdx1 (Ferredoxin 1) in MA-10 Leydig cells [7]. However, only luteolin is able to increase the cAMP-dependent progesterone synthesis in MA-10 Leydig cells. In addition, luteolin also activates Star expression and increases the productions of progesterone and testosterone in LC540 tumor Leydig cells [10]. Apigenin and chrysin have also been reported by others to increase cAMP-dependent androgen production from testis Leydig cells by enhancing the expression of the Star gene [71,72].
Chrysin and apigenin can reduce the protein levels of DAX1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on the X chromosome, gene 1), a major inhibitor of Star expression [72]. In Leydig cells from aging males, COX2 (cyclooxygenase-2) is associated with reduced expression of Star, leading to lower production of testosterone [73]. Interestingly, apigenin can inhibit Cox2 expression, leading to increased Star expression [72]. However, apigenin can also inhibit the production of 5α-androstane-3α, 17β-diol (DIOL), the major androgen produced by immature rat Leydig cells, as well as the steroidogenic enzymes HSD3B, CYP17A1 and HSD17B3 [74]. In addition, human HSD3B2, CYP17A1, and HSD17B3 were more sensitive to the inhibitory action of apigenin, decreasing androstenedione and testosterone productions in H295R human adrenal cells [75,76]. Overall, apigenin contributes to increased steroid production in Leydig cells by increasing PKA-dependent STAR protein levels. However, this effect may not result in improved testosterone synthesis, as apigenin also inhibits the expression of Cyp11a1 in LC540 tumor Leydig cells [10].
We have reported that luteolin can improve androgen production from Leydig cell by increasing Star expression [7,10]. Indeed, luteolin can increase cAMP-dependent steroid production by increasing STAR protein levels and the import of cholesterol inside mitochondria in MA-10 Leydig cells [77]. Luteolin can also increase Fdx1 expression in MA-10 Leydig cells [7]. FDX1 is involved in the electron transfer to support the activity of the steroidogenic enzyme CYP11A1. As for apigenin and chrysin, luteolin also inhibits Cox2 expression, thus improving Star transcription [78]. As reported for other flavonoids, luteolin also increases Star expression by reducing the expression of Dax1 [77].
The 5,7-dihydroxyflavone chrysin can be found in honey, chamomile, propolis, fruit bark as well as many plant extracts. In MA-10 Leydig cells, treatment with chrysin can stimulate cAMP-dependent androgen production by increasing STAR protein levels and steroidogenesis, possibly by decreasing Dax1 expression [71]. Chrysin can also inhibit the activity of NF-κB transcription factors, resulting in decreased activity of the COX2 promoter [79]. Reduced levels of COX2 in Leydig cells may promote Star expression. Chrysin is also an inhibitor of the aromatase enzyme, responsible for the conversion of testosterone into estradiol [80]. Such inhibitory action of flavonoids on the aromatase enzyme has also been attributed to apigenin [81]. Overall, chrysin can increase the serum levels of testosterone by more than 35% in adult male rats [82]. However, treatment with chrysin for 21 days had no effect on the urine concentration of testosterone in humans [83]. This may be explained by the low concentration of chrysin utilized in this study compared to those on rodents. However, treatment of male mice for 10 days with 20 mg/kg of chrysin prevents the inhibition of testosterone production following exposure to the mycotoxin zearalenone, but does not affect serum testosterone levels [84]. Therefore, chrysin may delay the age-related decline in STAR expression and testosterone production by Leydig cells [71,84,85]. However, chrysin did not induce an increase in steroid production when co-incubated with 22(R)hydroxycholesterol in MA-10 Leydig cells [71]. Thus, chrysin only enhances cholesterol entry into mitochondria via STAR and has no effect on the activities of enzymes involved in steroidogenesis. Recently, chrysin has been reported to improve recovery from heat stress, resulting in improved testosterone production from rat Leydig cells [86]. This flavone also protects against testicular apoptosis induced by torsion/detorsion and improves sperm quality in adult rat [87].
Baicalein can be found in several plants such as roots of Oroxylum indicum [88] and Scutellaria baicalensis Georgi [89]. As for other flavones, low concentrations of baicalein can improve cAMP-dependent activation of the Star promoter in MA-10 Leydig cells [7]. In addition, the activities of the Cyp11a1 and Fdx1 promoters are also increased by co-treatments with cAMP as observed with the other flavones luteolin, apigenin and chrysin. However, baicalein administration for 4 weeks has been reported to reduce serum levels of testosterone, FSH and LH following treatments of a rat polycystic ovary syndrome (PCOS) model [90]. In this study, baicalein rather decreases Star, Cyp11a1, Hsd3b, and Cyp19a1 expressions in ovarian tissues. Such a variation in responses to baicalein may be due to the sex of the animals and to the pathological state, such as PCOS. Overall, flavones appear to have an activating effect on the expression of steroidogenesis-related genes, including Star, in Leydig cells. However, these effects do not necessarily lead to an increase in androgen production.

4.1.2. Isoflavones

Isoflavones, such as genistein and daidzein, can be found in soybeans, red clover, alfalfa, and chickpeas. In mice, all testicular cell types express the estrogen receptor (ER)-β, while Leydig cells predominantly express ER-α [91]. In the testis, the aromatase enzyme is found mainly in Sertoli cells, enabling them to synthesize estrogen from androgen [92] and leading to ER-α-mediated inhibition of steroidogenesis in Leydig cells [93]. However, as adult Leydig cells produce increasingly higher levels of estrogen [94], the importance of this autocrine action on steroid production by Leydig cells remains to be better defined. With their phytoestrogenic effects, isoflavones can disrupt paracrine and autocrine estrogen signaling in the testis. Isoflavones have direct effects on the steroidogenic function of Leydig cells. Indeed, daidzein inhibits testosterone production by Leydig cells by decreasing Star, Cyp11a1 and Hsd3b1 expression levels in the testes of neonatal mice [95]. Genistein inhibits progesterone production by decreasing Star expression in MA-10 Leydig cells [96]. Furthermore, genistein also inhibits testosterone production in fetal mouse testes by decreasing expression levels of Star, Cyp11a1, Hsd3b1 and Cyp17a1 [97]. HSD3B and HSD17B3 enzyme activities are also inhibited by genistein in rat and human testes [98]. Thus, high concentrations of isoflavones may reduce steroidogenesis in the testis.
The different effects of flavonoids and isoflavones on androgen production can be explained by a structure-activity relationship. Indeed, isoflavones with the phenol group in position 3 of the C ring (Figure 1), such as daidzein and genistein, tend to inhibit the activities of the HSD3B2 and HSD17B3 enzymes, rather than aromatase [99]. This could explain the greater capacity of inhibition by isoflavones on testosterone production in H295R adrenal cells, compared to a flavonoid such as apigenin, whose phenolic group is in position 2 of the C ring [75].
Although several studies suggest that isoflavones contribute to lower testosterone levels in men, a meta-analysis of 32 studies concluded that neither soy foods nor isoflavone supplementation had significant effects on testosterone levels [100]. Furthermore, treatment of MA-10 Leydig cells with up to 100 μM genistein for 48 h has no effect on cell viability, progesterone synthesis and expression of steroidogenesis-related genes Star, Tspo, Cyp11a1 and Hsd3b1 [101]. However, Leydig cell proliferation and increased levels of STAR, CYP11A1, HSD3B and CYP17A1 are observed following exposure of perinatal male rats to soy isoflavones [102]. In contrast, exposure to genistein during perinatal development of male rodents results in reduced anogenital distance, decreased testicular mass and lower serum testosterone levels [103,104,105]. Specifically, a low concentration of 10 nM genistein inhibits testosterone production by fetal Leydig cells through interaction with the estrogen receptor α and decreases expression of the Star gene and of enzymes related to steroidogenesis [97]. Thus, exposure of the male fetus to phytoestrogens may disrupt testicular development and function.
The enzyme 5-α-reductase catalyzes the synthesis of 5-α-dihydrotestosterone (DHT) and is inhibited by genistein and daidzein in vitro [106], contributing to the reduction in serum levels of DHT in male rats [107]. This steroid can contribute to the development of prostate cancer [108]. While short-term treatment with genistein for 5 days result in a modest increase by less than 10% of plasma testosterone levels in Wistar rats [109], some have reported that a lifetime exposure to daidzein and genistein increases serum and testicular testosterone levels [110]. Others have shown that treatments with soy isoflavones daily for 8 weeks partially prevents the decrease in testosterone serum levels associated with aging in male rats [111]. However, a long-term consumption of daidzein and genistein impairs normal androgen production and reproductive function in male Wistar rats [112]. Hence, the effects of prolonged exposures to isoflavones on testosterone production may depend on the concentration, duration, as well as ratio of daidzein to genistein.
Interestingly, effects of genistein exposure of male pups from two weeks before birth until PND35 may be dependent on the concentration. Indeed, a low concentration of genistein (40 mg/kg) results in increased body weight, testosterone serum levels, testis weight and size of seminiferous epithelium, as well as increased expression of Esr2, Sox9, Brd7 and Cyp19a1 [113]. Oppositely, exposure to a high concentration of genistein (800 mg/kg) results in increased numbers of abnormal spermatids, higher apoptosis of germ cells, decreased diameter of seminiferous tubules, body and testis weights, whereas the expressions of Esr2 and Cyp19a1 were increased and the expression of Sox9 and Brd7 were decreased [113]. However, high concentration of genistein (800 mg/kg) has no effect on testosterone serum levels according to this study. Others have reported that soybean meal and genistin/daidzin diets decrease testosterone production regardless of the age of male rats due to decreases in STAR and HSD17B protein levels [114]. Genistin and daidzin are 7-O-β-D-glucosides of genistein and daidzein, respectively, and are metabolized into their aglycones during intestinal absorption. In addition, genistein and daidzein decrease LH stimulated testicular and Leydig cells’ testosterone production [114], suggesting that isoflavones mainly inhibit Leydig cells’ function rather than disrupting the entire hypothalamus–pituitary–gonadal (HPG) axis. Importantly, in a meta-analysis of clinical studies published between 2010 and 2022, no significant effects of soy isoflavones intake, regardless of dose and study duration, were found on testosterone levels in men [115].

4.1.3. Flavonols

With their ketone moiety, flavonols are the most oxidized flavonoids (Figure 1). Quercetin, myricetin and kaempferol are flavonols found in berries, apples, onions, broccoli, and tea. Flavonols have been well documented for their ability to enhance steroidogenesis and testicular function. Indeed, quercetin, myricetin or pentaacetylquercetin increase the cAMP-dependent expression of Star, Cyp11a1 and Fdx1, thus contributing to increased steroidogenesis in MA-10 Leydig cells [6]. However, quercetin supplementation of healthy men for 8 weeks has no effect on their serum testosterone levels [116]. This discrepancy in the effects of quercetin on testosterone synthesis can be explained by differences in its mechanism of action between species.
Quercetin improves steroid synthesis and testosterone levels in male mice exposed to the endocrine disruptor bisphenol A [117]. Indeed, quercetin increases the transcriptional activity of CREB1, as well as the promoter activities of Cyp11a1 and Fdx1 [6]. The CREB1 transcription factor is an important activator of steroidogenic genes, including Star, in Leydig cells [118,119,120]. Thus, quercetin increases Star promoter activity, Star mRNA levels and steroid production in MA-10 Leydig cells [96]. This quercetin-dependent increase in the expression of the Star gene in response to cAMP can also be attributed to the decrease in DAX1 protein levels in Leydig cells [77]. In addition, Star expression and steroidogenesis may be enhanced by inhibition of COX2 signaling following treatment with quercetin, as observed with chrysin, apigenin or luteolin in Leydig cells [77]. The activity of COX2 increases in aged Leydig cells, leading to repression of Star gene expression and androgen production [73]. Hence, consumption of polyphenolic antioxidants, including flavonoids, may delay the decline in age-related androgen production in men. Quercetin can also inhibit endoplasmic reticulum stress and improve testosterone production in streptozotocin-induced diabetic male rats and high glucose-treated Leydig cells [121]. Moreover, quercetin can enhance testosterone synthesis in rats exposed to cadmium chloride or the herbicide atrazine by improving the activities of the HSD3B and HSD17B3 enzymes [122,123]. We have also confirmed that quercetin can increase Hsd3b expression in rat LC540 Leydig cells [10]. In addition, quercetin-derived molecules such as pentaacetylquercetin can activate Star and Cyp11a1 expression, leading to an increase in cAMP-dependent progesterone accumulation in MA-10 Leydig cells [6]. This acetylation of quercetin may improve its bioavailability in vivo.
Icariin, a prenylated flavonol glycoside, has been found in several plant species of the genus Epimedium, including horny goat weed. Icariin can reverse the negative effects of di(2-ethylhexyl) phthalate (DEHP) on the proliferation and testosterone synthesis capacities of primary Leydig cells [124]. Indeed, icariin prevents DEHP-induced decreases in the expression of steroidogenic enzymes (CYP11A1, HSD3B1 and HSD17B3) and of the transcription factor NR5A1 (SF-1), an important regulator of the expression of steroidogenic genes [125,126]. In addition, icariin increases the expression of TSPO and STAR, facilitating cholesterol entry into mitochondria and promoting testosterone production in adult male rat testes [127]. Icariin also improves the expression of Star and Hsd3b1, as well as of genes encoding superoxide dismutase (Sod1, Sod3) and glutathione peroxidase (Gpx1), leading to increased serum levels of testosterone after 35 days of treatment of male mice [128]. However, icariin also activates the apoptosis of mouse Leydig tumor cells (mLTC1) [129].
Rutin is a glycosylated quercetin commonly found in citrus fruits. It has been shown to reduce the decline in serum LH, FSH and testosterone levels, as well as improving sperm quality, following exposure of male rats to carbon tetrachloride, a major environmental contaminant [130]. Rutin also reduces the decrease in serum testosterone levels in response to cadmium by increasing the activities of HSD3B and HSD17B3 enzymes in male rats [131,132]. In addition, rutin can improve the expressions of Cyp11a1 and Hsd3b1, but with no effect on serum testosterone levels in male rats [133]. However, others reported that rutin rather inhibits basal and LH-induced secretions of androgen by rat immature Leydig cells by decreasing the expressions of Scarb1, Cyp11a1 and Hsd3b1 [134].
Taxifolin or dihydroquercetin belongs to the flavanonol subclass and is found in red onions. This molecule inhibits the enzymes HSD3B and CYP17A1, leading to a reduction in androgen production in immature rat Leydig cells [135]. In contrast, human HSD3B2 and CYP17A1 enzymes are less sensitive to taxifolin. Overall, flavonols are natural antioxidants that can enhance the activities of steroidogenic enzyme and prevent age-related declines in androgen production in men.

4.1.4. Flavanones

Flavanones lack a double bond in their C ring (Figure 2). The flavanone naringenin, found in grapefruits, inhibits the activities of HSD17B3 and HSD3B enzymes in male rat testes [136]. However, treatments of male rats with naringenin for 10 weeks results in increased serum levels of testosterone [137]. Hence, the conditions of flavonoid treatments, such as concentration, duration and route of administration, can influence the results in certain experimental models. Naringenin also prevents the decrease in serum testosterone and inhibin B in rats treated with chemotherapeutic agents such as cisplatin and doxorubicin [138]. In addition, cadmium-induced testicular toxicity can be reduced by treatment of male rats with naringenin, resulting in partial recoveries of GnRH, FSH, LH and testosterone serum levels [139]. Naringin, a flavanone-7-O-glycoside derived from naringenin, is also able to improve testosterone production in response to treatments with bisphenol A or high fat diet-induced diabetes in male rats [140,141]. Hesperetin, a flavanone found in citrus fruits, can also prevent reduced testosterone production in diabetic rats [142]. In addition, hesperidin, a glycosylated form of hesperetin, can prevent the decline in testosterone serum levels resulting from exposure to DEHP of male Wistar rats [143]. Hesperidin glycoside, also found in citrus fruits, prevents a decrease in serum testosterone levels in male rats treated with vanadium [144]. Thus, flavanones are promising natural antioxidants for limiting the decline in androgen levels in response to endocrine disruptors and possibly aging.

4.1.5. Catechins

Catechins are distinguished by the lack of a double bond in the C ring and by the presence of an -OH group in position-3 of this ring (Figure 2). With dihydrochalcones, catechins are the most reduced flavonoids. Catechins are mainly found in apples, red wine and tea. Catechin, epicatechin and epigallocatechin gallate (EGCG) are able to increase plasma levels of testosterone in male rats [145]. Indeed, catechins increase testosterone production in response to hCG in rat Leydig cells [145]. In addition, epicatechin increases the activity of the HSD17B3 enzyme. However, others have shown that green tea polyphenols rather inhibit androgen synthesis in rat Leydig cells via inhibition of the PKA/PKC signaling pathways, and of the CYP11A1 and HSD17B3 enzymes [146]. Furthermore, long-term consumption of green tea is associated with an increase in aromatase expression, leading to a decrease in plasma levels of testosterone in humans [147]. In contrast, catechin inhibits aromatase activity, leading to an increase in plasma testosterone levels in male rats [148]. Furthermore, catechin injections also contribute to increasing plasma testosterone levels [145]. Green tea EGCG inhibits the productions of progesterone and estradiol in porcine granulosa cells [149]. In contrast, EGCG also inhibits the activities of the PKA/PKC signaling pathways, and the enzymes CYP11A1 and HSD17B3, leading to a reduction in testosterone production in primary Leydig cells [146]. Overall, these contradictory effects of catechins on plasma testosterone levels require further research to better define their mechanisms of action and could be attributed to different actions of catechins depending on the species.

4.1.6. Anthocyanidins

Anthocyanidins are characterized by a positive charge and two double bonds on the C ring (Figure 2). Berries, currants, grapes, tropical fruits, as well as wine and tea, are rich in these colored pigments. Anthocyanidins are known for their antioxidant and antimicrobial capacities [150]. These flavonoids may improve steroidogenesis through their inhibitory activity against COX2 and their capacities to modulate the activity of the MAPK signaling pathway [151,152], promoting STAR protein expression and activity in Leydig cells. Cyanidin-3-glucoside prevents lead (Pb)-induced inhibition of progesterone production in R2C Leydig cells by preserving the integrity of mitochondria and increasing the expression of steroidogenic genes Star, Hsd3b and Cyp11a1 [153]. This anthocyanin also activates the MAPK and PKA signaling pathways [153], thus promoting steroid synthesis. Cyanidin-3-glucoside also enhances testicular expression of the steroidogenic proteins STAR, CYP11A1 and HSD3B, as well as the LH receptor, in mice exposed to cadmium, a major neuro-endocrine disruptor [154]. Therefore, anthocyanidins may enhance testosterone production by Leydig cells via their antioxidant capacities.

4.2. Hydroxycinnamic Acid Phenethyl Ester Derivatives

Present in many plants, hydroxycinnamic acids are biosynthesized via the shikimic pathway with L-tyrosine or L-phenylalanine, via methylation, deamination, or hydroxylation reactions [155]. We recently reported that treatments with 10 μM of sinapic or ferulic acid phenethyl esters (Figure 3) increase progesterone production in MA-10 Leydig cells [9]. Moreover, genes encoding enzymes contributing to cholesterol and steroid biosynthesis are increased by sinapic acid phenethyl ester, whereas ferulic acid phenethyl ester increases cAMP-dependent STAR protein expression. In addition, others have reported that caffeic acid phenethyl ester (Figure 3) reduces cadmium-induced apoptosis of Leydig cells and disruption of the production of testosterone [156]. Thus, these studies suggest that methoxycinnamic acid phenethyl ester derivatives can enhance androgen production by Leydig cells by improving the expression of steroidogenesis-related genes.
Also having hydroxy-methoxyphenyl groups, curcumin rather decreases LH-stimulated testosterone production by inhibiting the HSD17B1 enzyme in adult rat Leydig cells [157]. In addition, curcumin inhibits cAMP-induced steroidogenesis by inhibiting the levels of STAR and CYP11A1 in mouse Leydig cells [158].

4.3. Resveratrol and Gigantol

Resveratrol (3,4′,5-trihydroxy-trans-stilbene, Figure 4) is a polyphenol found in grapes, berries, peanuts, plums and red wine. As for flavonoids, it is essential for protecting plants from environmental stress and pathogen invasions [159]. Because of its structural similarity with estradiol, resveratrol is qualified as a phytoestrogen [160].
Numerous studies have reported that resveratrol enhances spermatogenesis, testosterone production and sperm quality [161,162]. However, others have reported that resveratrol disrupts LH-stimulated androgen production by Leydig cells by inhibiting the HSD3B1 enzyme in immature rats [163]. In addition, resveratrol can also inhibit the expression of STAR and CYP17A1 in rat Leydig cells [164], as well as Star promoter activity in mouse MA-10 Leydig cells [96]. Inhibition of androgen production by resveratrol may also involve its capacity to activate the adenosine monophosphate-activated protein kinase (AMPK) [165], known to inhibit the expression of important regulators of steroidogenesis, such as the transcription factor NR4A1 and STAR, in Leydig cells [166]. On the other hand, others suggest that resveratrol is promising for the treatment of male obesity-associated secondary hypogonadism. Indeed, resveratrol prevents the decrease in the expressions of Star, Cyp11a1, Cyp17a1 and Hsd17b3 and restores testosterone serum levels in response to a high-caloric diet in mice [167]. In addition, resveratrol can also upregulate mitochondrial biogenesis and steroidogenesis in aged Leydig cells [168], potentially reducing the symptoms of late-onset male hypogonadism. Furthermore, aging Leydig cells are exposed to increasing levels of oxidative stress, and resveratrol can prevent the detrimental effects of such stress on mitochondrial function and steroidogenesis, as reported in TM3 Leydig cells [169,170]. Others have also reported that resveratrol can reduce nicotine-induced oxidative damage in TM3 Leydig cells by upregulating autophagy through activation of the AMPK pathway [170].
Interestingly, a microgreen extract from cress (Lepidium sativum) rich in ferulic acid and resveratrol can improve steroid production from TM3 Leydig cells following exposure with 250 μg/mL of extract for 48 h [171]. In one of our latest research, we’ve shown that gigantol (Figure 4), a bibenzyl compound isolated from orchids, can improve progesterone production in MA-10 Leydig cells by increasing the expression of genes involved in the biosynthesis of cholesterol and its import into mitochondria [8]. Thus, gigantol and resveratrol are phenolic compounds with great potential for preventing age-related declines in androgen production in men.

5. Other Actions of Natural Antioxidants

5.1. Effects of Natural Antioxidants on the Hypothalamus

Natural polyphenolic compounds have been studied for their potential effects on the hypothalamus, a regulatory center for various physiological processes. Potential effects of polyphenolic compounds on the hypothalamus include neuroprotection, hormone regulation, energy balance, and neurogenesis. Polyphenolic compounds, such as flavonoids, have been shown to possess antioxidant and anti-inflammatory properties that may help protect neurons in the hypothalamus from oxidative stress and neuroinflammation [172], potentially preserving hypothalamic function during aging. Polyphenolic compounds also modulate hormone secretion from the hypothalamus, influencing the release of various hormones such as GnRH [173], which controls the release of reproductive hormones LH and FSH. Recent evidence suggests that polyphenolic compounds may promote neurogenesis in the hypothalamus [174], which could have implications for cognitive function and overall brain health. However, only genistein has been reported to directly increase GnRH release from the mouse hypothalamic cell line GT1-7, potentially affecting reproductive function [175]. Hence, the specific mechanisms by which polyphenolic compounds regulate GnRH secretion and their implications in the regulation of testosterone production in aging males require further investigation.

5.2. Effects of Natural Antioxidants on the Pituitary Gland

Besides the hypothalamus, natural polyphenolic compounds may influence hormone production and release from the pituitary gland. Polyphenolic compounds may influence different functions of the pituitary gland, such as LH and FSH secretion and stress response, having effects on testicular androgen production. These compounds may also influence the pulsatile release of GnRH from the hypothalamus or directly affect pituitary gonadotroph cells.
Some polyphenolic compounds have been studied for their potential inhibitory effects on the pituitary gland-adrenal axis [176,177], which regulates the body’s response to stress and may influence testicular androgen production. These compounds may reduce the secretion of ACTH from the pituitary gland, leading to decreased cortisol release from the adrenal glands, thereby having an anti-stress effect. Indeed, polyphenol-rich dark chocolate has been reported to lower salivary cortisol in adults [178]. Cortisol may decrease cAMP-induced Star expression in Leydig cells as reported using the synthetic glucocorticoid dexamethasone [179]. However, the effects of polyphenols in reducing ACTH and cortisol levels on androgen production in the testis will require further study to be confirmed and may be the result of multiple actions of these natural antioxidants.
Several specific polyphenolic compounds have been investigated for their potential effects on LH release from the pituitary gland. EGCG and green tea extract have been reported to inhibit LH release from the pituitary gland [180], potentially influencing reproductive function in males. Although the LH pulses were decreased by intravenous administration of the phytoestrogen coumestrol, genistein had no effect on LH release from female rats [181]. However, the effects of genistein on LH secretion may vary depending on treatment conditions such as dose, duration of exposure, and sex of the animals. While some studies suggest that polyphenolic compounds influence LH release from the pituitary gland, further research is needed to fully understand their mechanisms of action and overall effects, as well as the contribution to prevention of male late-onset hypogonadism.

5.3. Influences of Natural Antioxidants on Liver Function and Testosterone Bioavailability

Liver function is very important for testosterone bioavailability, as steroid transport proteins such as albumin and SHBG are synthesized by the liver and released into the bloodstream. Natural antioxidants, such as polyphenolic compounds, have been studied for their potential influences on liver function and testosterone bioavailability. Overall, natural antioxidants can positively influence liver function by reducing oxidative stress, inflammation, and liver damage. Resveratrol is a well-known polyphenol having hepatoprotective properties [182,183]. It has been shown to reduce oxidative stress [184], inflammation [182], and liver damage [185,186]. Quercetin also has antioxidant and anti-inflammatory properties that benefit liver health [187]. It has been found to protect against liver damage and inflammation induced by toxins and alcohol [188,189,190]. EGCG also reduces liver inflammation, oxidative stress, and fat accumulation, potentially preventing liver diseases such as non-alcoholic fatty liver disease (NAFLD) [191,192]. Curcumin has been shown to protect the liver from damage caused by toxins, drugs, and various liver diseases [193,194]. Apigenin also exhibits hepatoprotective effects by reducing inflammation and oxidative stress in the liver [195,196].
Natural polyphenolic compounds may also influence testosterone bioavailability by regulating the liver’s production of SHBG and albumin. Indeed, the plasma levels of these transport proteins interacting with steroid hormones, including androgens, influence total and free testosterone plasma concentrations. It is particularly the free form of testosterone that is responsible for its physiological actions. Age and low protein intake are major determinants of elevated SHBG serum levels and decreased testosterone bioavailability in older men [197]. Thus, more efficient production of these transport proteins by the liver in the presence of natural polyphenolic compounds could limit the symptoms of age-related male hypogonadism. However, more research is needed to confirm a direct inhibitory action of polyphenolic compounds on SHBG and albumin synthesis by the liver.

6. Conclusions

Importantly, plasma levels of natural polyphenolic compounds in the low micromolar range can be achieved with a high-quality diet consisting mainly of fruits and vegetables and are adequate for optimal testicular Leydig cells’ functions. Based on the research literature and our data, flavonoids with a 5,7-dihydroxychromen-4-one backbone have been observed to activate Star expression, leading to improved androgen synthesis by Leydig cells from the testis (Figure 5). While many polyphenols have activating or inhibitory actions on androgen biosynthesis, the combined exposure to natural polyphenolic compounds and their potential synergistic effects on steroidogenesis should be considered.

Author Contributions

Writing—original draft preparation, L.J.M. and M.T.; writing—review and editing, L.J.M. and M.T.; funding acquisition, L.J.M. and M.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada (grant numbers: 05219 to L.J.M. and 04560 to M.T.).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Gray, A.; Feldman, H.A.; McKinlay, J.B.; Longcope, C. Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 1991, 73, 1016–1025. [Google Scholar] [CrossRef] [PubMed]
  2. Dandona, P.; Rosenberg, M.T. A Practical Guide to Male Hypogonadism in the Primary Care Setting. Int. J. Clin. Pract. 2010, 64, 682–696. [Google Scholar] [CrossRef]
  3. Midzak, A.S.; Chen, H.; Papadopoulos, V.; Zirkin, B.R. Leydig Cell Aging and the Mechanisms of Reduced Testosterone Synthesis. Mol. Cell. Endocrinol. 2009, 299, 23–31. [Google Scholar] [CrossRef] [PubMed]
  4. Matsumoto, A.M. Andropause: Clinical Implications of the Decline in Serum Testosterone Levels with Aging in Men. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2002, 57, M76–M99. [Google Scholar] [CrossRef]
  5. Kumar, P.; Kumar, N.; Thakur, D.S.; Patidar, A. Male Hypogonadism: Symptoms and Treatment. J. Adv. Pharm. Technol. Res. 2010, 1, 297–301. [Google Scholar] [CrossRef] [PubMed]
  6. Cormier, M.; Ghouili, F.; Roumaud, P.; Martin, L.J.; Touaibia, M. Influence of Flavonols and Quercetin Derivative Compounds on MA-10 Leydig Cells Steroidogenic Genes Expressions. Toxicol. In Vitro 2017, 44, 111–121. [Google Scholar] [CrossRef] [PubMed]
  7. Cormier, M.; Ghouili, F.; Roumaud, P.; Bauer, W.; Touaibia, M.; Martin, L.J. Influences of Flavones on Cell Viability and cAMP-Dependent Steroidogenic Gene Regulation in MA-10 Leydig Cells. Cell Biol. Toxicol. 2018, 34, 23–38. [Google Scholar] [CrossRef]
  8. Basque, A.; Nguyen, H.T.; Touaibia, M.; Martin, L.J. Gigantol Improves Cholesterol Metabolism and Progesterone Biosynthesis in MA-10 Leydig Cells. Curr. Issues Mol. Biol. 2022, 44, 73–93. [Google Scholar] [CrossRef]
  9. Basque, A.; Touaibia, M.; Martin, L.J. Sinapic and Ferulic Acid Phenethyl Esters Increase the Expression of Steroidogenic Genes in MA-10 Tumor Leydig Cells. Toxicol. In Vitro 2023, 86, 105505. [Google Scholar] [CrossRef]
  10. Couture, R.; Mora, N.; Al Bittar, S.; Najih, M.; Touaibia, M.; Martin, L.J. Luteolin Modulates Gene Expression Related to Steroidogenesis, Apoptosis, and Stress Response in Rat LC540 Tumor Leydig Cells. Cell Biol. Toxicol. 2020, 36, 31–49. [Google Scholar] [CrossRef]
  11. Niu, Y.; Liao, J.; Zhou, H.; Wang, C.-C.; Wang, L.; Fan, Y. Flavonoids from Lycium Barbarum Leaves Exhibit Anti-Aging Effects through the Redox-Modulation. Molecules 2022, 27, 4952. [Google Scholar] [CrossRef] [PubMed]
  12. Remigante, A.; Spinelli, S.; Straface, E.; Gambardella, L.; Russo, M.; Cafeo, G.; Caruso, D.; Falliti, G.; Dugo, P.; Dossena, S.; et al. Mechanisms Underlying the Anti-Aging Activity of Bergamot (Citrus bergamia) Extract in Human Red Blood Cells. Front. Physiol. 2023, 14, 1225552. [Google Scholar] [CrossRef] [PubMed]
  13. Cui, Z.; Zhao, X.; Amevor, F.K.; Du, X.; Wang, Y.; Li, D.; Shu, G.; Tian, Y.; Zhao, X. Therapeutic Application of Quercetin in Aging-Related Diseases: SIRT1 as a Potential Mechanism. Front. Immunol. 2022, 13, 943321. [Google Scholar] [CrossRef] [PubMed]
  14. Genissel, C.; Levallet, J.; Carreau, S. Regulation of Cytochrome P450 Aromatase Gene Expression in Adult Rat Leydig Cells: Comparison with Estradiol Production. J. Endocrinol. 2001, 168, 95–105. [Google Scholar] [CrossRef] [PubMed]
  15. Abney, T.O. The Potential Roles of Estrogens in Regulating Leydig Cell Development and Function: A Review. Steroids 1999, 64, 610–617. [Google Scholar] [CrossRef] [PubMed]
  16. Eacker, S.M.; Agrawal, N.; Qian, K.; Dichek, H.L.; Gong, E.-Y.; Lee, K.; Braun, R.E. Hormonal Regulation of Testicular Steroid and Cholesterol Homeostasis. Mol. Endocrinol. 2008, 22, 623–635. [Google Scholar] [CrossRef] [PubMed]
  17. Stocco, D.M. Tracking the Role of a Star in the Sky of the New Millennium. Mol. Endocrinol. 2001, 15, 1245–1254. [Google Scholar] [CrossRef] [PubMed]
  18. Gazouli, M.; Yao, Z.-X.; Boujrad, N.; Corton, J.C.; Culty, M.; Papadopoulos, V. Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor Alpha. Endocrinology 2002, 143, 2571–2583. [Google Scholar] [CrossRef]
  19. Payne, A.H.; Hales, D.B. Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones. Endocr. Rev. 2004, 25, 947–970. [Google Scholar] [CrossRef]
  20. Culty, M.; Luo, L.; Yao, Z.-X.; Chen, H.; Papadopoulos, V.; Zirkin, B.R. Cholesterol Transport, Peripheral Benzodiazepine Receptor, and Steroidogenesis in Aging Leydig Cells. J. Androl. 2002, 23, 439–447. [Google Scholar] [CrossRef]
  21. Leers-Sucheta, S.; Stocco, D.M.; Azhar, S. Down-Regulation of Steroidogenic Acute Regulatory (StAR) Protein in Rat Leydig Cells: Implications for Regulation of Testosterone Production during Aging. Mech. Ageing Dev. 1999, 107, 197–203. [Google Scholar] [CrossRef] [PubMed]
  22. Wang, X.; Stocco, D.M. The Decline in Testosterone Biosynthesis during Male Aging: A Consequence of Multiple Alterations. Mol. Cell. Endocrinol. 2005, 238, 1–7. [Google Scholar] [CrossRef] [PubMed]
  23. Martin, L.J.; Touaibia, M. Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism. Antioxidants 2020, 9, 237. [Google Scholar] [CrossRef] [PubMed]
  24. Evaul, K.; Hammes, S.R. Cross-Talk between G Protein-Coupled and Epidermal Growth Factor Receptors Regulates Gonadotropin-Mediated Steroidogenesis in Leydig Cells. J. Biol. Chem. 2008, 283, 27525–27533. [Google Scholar] [CrossRef] [PubMed]
  25. Matzkin, M.E.; Yamashita, S.; Ascoli, M. The ERK1/2 Pathway Regulates Testosterone Synthesis by Coordinately Regulating the Expression of Steroidogenic Genes in Leydig Cells. Mol. Cell. Endocrinol. 2013, 370, 130–137. [Google Scholar] [CrossRef] [PubMed]
  26. Roumaud, P.; Martin, L.J. Roles of Leptin, Adiponectin and Resistin in the Transcriptional Regulation of Steroidogenic Genes Contributing to Decreased Leydig Cells Function in Obesity. Horm. Mol. Biol. Clin. Investig. 2015, 24, 25–45. [Google Scholar] [CrossRef] [PubMed]
  27. Landry, D.A.; Sormany, F.; Haché, J.; Roumaud, P.; Martin, L.J. Steroidogenic Genes Expressions Are Repressed by High Levels of Leptin and the JAK/STAT Signaling Pathway in MA-10 Leydig Cells. Mol. Cell. Biochem. 2017, 433, 79–95. [Google Scholar] [CrossRef]
  28. Martin, L.J.; Boucher, N.; Brousseau, C.; Tremblay, J.J. The Orphan Nuclear Receptor NUR77 Regulates Hormone-Induced StAR Transcription in Leydig Cells through Cooperation with Ca2+/Calmodulin-Dependent Protein Kinase I. Mol. Endocrinol. 2008, 22, 2021–2037. [Google Scholar] [CrossRef] [PubMed]
  29. Manna, P.R.; Jo, Y.; Stocco, D.M. Regulation of Leydig Cell Steroidogenesis by Extracellular Signal-Regulated Kinase 1/2: Role of Protein Kinase A and Protein Kinase C Signaling. J. Endocrinol. 2007, 193, 53–63. [Google Scholar] [CrossRef]
  30. Jo, Y.; King, S.R.; Khan, S.A.; Stocco, D.M. Involvement of Protein Kinase C and Cyclic Adenosine 3′,5′-Monophosphate-Dependent Kinase in Steroidogenic Acute Regulatory Protein Expression and Steroid Biosynthesis in Leydig Cells. Biol. Reprod. 2005, 73, 244–255. [Google Scholar] [CrossRef]
  31. Garza, S.; Papadopoulos, V. Testosterone Recovery Therapy Targeting Dysfunctional Leydig Cells. Andrology 2023, 11, 816–825. [Google Scholar] [CrossRef] [PubMed]
  32. Basualto-Alarcón, C.; Varela, D.; Duran, J.; Maass, R.; Estrada, M. Sarcopenia and Androgens: A Link between Pathology and Treatment. Front. Endocrinol. 2014, 5, 217. [Google Scholar] [CrossRef] [PubMed]
  33. Tuck, S.; Francis, R. Testosterone, Bone and Osteoporosis. Front. Horm. Res. 2009, 37, 123–132. [Google Scholar] [CrossRef] [PubMed]
  34. Corona, G.; Maggi, M. The Role of Testosterone in Erectile Dysfunction. Nat. Rev. Urol. 2010, 7, 46–56. [Google Scholar] [CrossRef] [PubMed]
  35. Straftis, A.A.; Gray, P.B. Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone. Int. J. Environ. Res. Public Health 2019, 16, 3261. [Google Scholar] [CrossRef]
  36. Kelly, D.M.; Jones, T.H. Testosterone: A Metabolic Hormone in Health and Disease. J. Endocrinol. 2013, 217, R25–R45. [Google Scholar] [CrossRef] [PubMed]
  37. Blaya, R.; Blaya, P.; Rhoden, L.; Rhoden, E.L. Low Testosterone Levels and Metabolic Syndrome in Aging Male. Curr. Pharm. Des. 2017, 23, 4470–4474. [Google Scholar] [CrossRef] [PubMed]
  38. Moffat, S.D.; Zonderman, A.B.; Metter, E.J.; Blackman, M.R.; Harman, S.M.; Resnick, S.M. Longitudinal Assessment of Serum Free Testosterone Concentration Predicts Memory Performance and Cognitive Status in Elderly Men. J. Clin. Endocrinol. Metab. 2002, 87, 5001–5007. [Google Scholar] [CrossRef]
  39. Huang, G.; Wharton, W.; Bhasin, S.; Harman, S.M.; Pencina, K.M.; Tsitouras, P.; Li, Z.; Hally, K.A.; Asthana, S.; Storer, T.W.; et al. Effects of Long-Term Testosterone Administration on Cognition in Older Men with Low or Low-to-Normal Testosterone Concentrations: A Prespecified Secondary Analysis of Data from the Randomised, Double-Blind, Placebo-Controlled TEAAM Trial. Lancet Diabetes Endocrinol. 2016, 4, 657–665. [Google Scholar] [CrossRef]
  40. Beauchet, O. Testosterone and Cognitive Function: Current Clinical Evidence of a Relationship. Eur. J. Endocrinol. 2006, 155, 773–781. [Google Scholar] [CrossRef]
  41. Lv, W.; Du, N.; Liu, Y.; Fan, X.; Wang, Y.; Jia, X.; Hou, X.; Wang, B. Low Testosterone Level and Risk of Alzheimer’s Disease in the Elderly Men: A Systematic Review and Meta-Analysis. Mol. Neurobiol. 2016, 53, 2679–2684. [Google Scholar] [CrossRef] [PubMed]
  42. Joshi, D.; van Schoor, N.M.; de Ronde, W.; Schaap, L.A.; Comijs, H.C.; Beekman, A.T.F.; Lips, P. Low Free Testosterone Levels Are Associated with Prevalence and Incidence of Depressive Symptoms in Older Men. Clin. Endocrinol. 2010, 72, 232–240. [Google Scholar] [CrossRef] [PubMed]
  43. Mäkelä, J.-A.; Koskenniemi, J.J.; Virtanen, H.E.; Toppari, J. Testis Development. Endocr. Rev. 2019, 40, 857–905. [Google Scholar] [CrossRef] [PubMed]
  44. Robaire, B.; Hamzeh, M. Androgen Action in the Epididymis. J. Androl. 2011, 32, 592–599. [Google Scholar] [CrossRef]
  45. Tsuji, M.; Shima, H.; Cunha, G.R. Morphogenetic and Proliferative Effects of Testosterone and Insulin on the Neonatal Mouse Seminal Vesicle in Vitro. Endocrinology 1991, 129, 2289–2297. [Google Scholar] [CrossRef] [PubMed]
  46. Wilson, J.D. The Critical Role of Androgens in Prostate Development. Endocrinol. Metab. Clin. N. Am. 2011, 40, 577–590. [Google Scholar] [CrossRef] [PubMed]
  47. Baskin, L.S.; Sutherland, R.S.; DiSandro, M.J.; Hayward, S.W.; Lipschutz, J.; Cunha, G.R. The Effect of Testosterone on Androgen Receptors and Human Penile Growth. J. Urol. 1997, 158, 1113–1118. [Google Scholar] [CrossRef] [PubMed]
  48. Griggs, R.C.; Kingston, W.; Jozefowicz, R.F.; Herr, B.E.; Forbes, G.; Halliday, D. Effect of Testosterone on Muscle Mass and Muscle Protein Synthesis. J. Appl. Physiol. 1989, 66, 498–503. [Google Scholar] [CrossRef] [PubMed]
  49. Katznelson, L.; Finkelstein, J.S.; Schoenfeld, D.A.; Rosenthal, D.I.; Anderson, E.J.; Klibanski, A. Increase in Bone Density and Lean Body Mass during Testosterone Administration in Men with Acquired Hypogonadism. J. Clin. Endocrinol. Metab. 1996, 81, 4358–4365. [Google Scholar] [CrossRef]
  50. Brodnitz, F.S. Hormones and the Human Voice. Bull. N. Y. Acad. Med. 1971, 47, 183–191. [Google Scholar]
  51. Randall, V.A. Androgens and Hair Growth. Dermatol. Ther. 2008, 21, 314–328. [Google Scholar] [CrossRef] [PubMed]
  52. Walker, W.H. Testosterone Signaling and the Regulation of Spermatogenesis. Spermatogenesis 2011, 1, 116–120. [Google Scholar] [CrossRef] [PubMed]
  53. Tilbrook, A.J.; Clarke, I.J. Negative Feedback Regulation of the Secretion and Actions of Gonadotropin-Releasing Hormone in Males. Biol. Reprod. 2001, 64, 735–742. [Google Scholar] [CrossRef] [PubMed]
  54. Nam, Y.S.; Lee, G.; Yun, J.M.; Cho, B. Testosterone Replacement, Muscle Strength, and Physical Function. World J. Mens Health 2018, 36, 110–122. [Google Scholar] [CrossRef] [PubMed]
  55. Mohamad, N.-V.; Soelaiman, I.-N.; Chin, K.-Y. A Concise Review of Testosterone and Bone Health. Clin. Interv. Aging 2016, 11, 1317–1324. [Google Scholar] [CrossRef] [PubMed]
  56. Saggese, G.; Baroncelli, G.I.; Bertelloni, S. Puberty and Bone Development. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16, 53–64. [Google Scholar] [CrossRef] [PubMed]
  57. Richmond, E.J.; Rogol, A.D. Male Pubertal Development and the Role of Androgen Therapy. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3, 338–344. [Google Scholar] [CrossRef] [PubMed]
  58. Beggs, L.A.; Yarrow, J.F.; Conover, C.F.; Meuleman, J.R.; Beck, D.T.; Morrow, M.; Zou, B.; Shuster, J.J.; Borst, S.E. Testosterone Alters Iron Metabolism and Stimulates Red Blood Cell Production Independently of Dihydrotestosterone. Am. J. Physiol. Endocrinol. Metab. 2014, 307, E456–E461. [Google Scholar] [CrossRef] [PubMed]
  59. Wang, C.; Alexander, G.; Berman, N.; Salehian, B.; Davidson, T.; McDonald, V.; Steiner, B.; Hull, L.; Callegari, C.; Swerdloff, R.S. Testosterone Replacement Therapy Improves Mood in Hypogonadal Men--a Clinical Research Center Study. J. Clin. Endocrinol. Metab. 1996, 81, 3578–3583. [Google Scholar] [CrossRef]
  60. Westley, C.J.; Amdur, R.L.; Irwig, M.S. High Rates of Depression and Depressive Symptoms among Men Referred for Borderline Testosterone Levels. J. Sex. Med. 2015, 12, 1753–1760. [Google Scholar] [CrossRef]
  61. Zitzmann, M. Testosterone, Mood, Behaviour and Quality of Life. Andrology 2020, 8, 1598–1605. [Google Scholar] [CrossRef] [PubMed]
  62. Johnson, J.M.; Nachtigall, L.B.; Stern, T.A. The Effect of Testosterone Levels on Mood in Men: A Review. Psychosomatics 2013, 54, 509–514. [Google Scholar] [CrossRef] [PubMed]
  63. Corona, G.; Maggi, M. The Role of Testosterone in Male Sexual Function. Rev. Endocr. Metab. Disord. 2022, 23, 1159–1172. [Google Scholar] [CrossRef] [PubMed]
  64. Rastrelli, G.; Corona, G.; Maggi, M. Testosterone and Sexual Function in Men. Maturitas 2018, 112, 46–52. [Google Scholar] [CrossRef] [PubMed]
  65. De Maddalena, C.; Vodo, S.; Petroni, A.; Aloisi, A.M. Impact of Testosterone on Body Fat Composition. J. Cell. Physiol. 2012, 227, 3744–3748. [Google Scholar] [CrossRef] [PubMed]
  66. Havsteen, B.H. The Biochemistry and Medical Significance of the Flavonoids. Pharmacol. Ther. 2002, 96, 67–202. [Google Scholar] [CrossRef] [PubMed]
  67. Rauter, A.P.; Ennis, M.; Hellwich, K.-H.; Herold, B.J.; Horton, D.; Moss, G.P.; Schomburg, I. Nomenclature of Flavonoids (IUPAC Recommendations 2017). Pure Appl. Chem. 2018, 90, 1429–1486. [Google Scholar] [CrossRef]
  68. Chen, X.; Mukwaya, E.; Wong, M.-S.; Zhang, Y. A Systematic Review on Biological Activities of Prenylated Flavonoids. Pharm. Biol. 2014, 52, 655–660. [Google Scholar] [CrossRef]
  69. Daina, A.; Michielin, O.; Zoete, V. SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules. Sci. Rep. 2017, 7, 42717. [Google Scholar] [CrossRef]
  70. Kozłowska, A.; Szostak-Wegierek, D. Flavonoids--Food Sources and Health Benefits. Rocz. Panstw. Zakl. Hig. 2014, 65, 79–85. [Google Scholar]
  71. Jana, K.; Yin, X.; Schiffer, R.B.; Chen, J.-J.; Pandey, A.K.; Stocco, D.M.; Grammas, P.; Wang, X. Chrysin, a Natural Flavonoid Enhances Steroidogenesis and Steroidogenic Acute Regulatory Protein Gene Expression in Mouse Leydig Cells. J. Endocrinol. 2008, 197, 315–323. [Google Scholar] [CrossRef]
  72. Li, W.; Pandey, A.K.; Yin, X.; Chen, J.-J.; Stocco, D.M.; Grammas, P.; Wang, X. Effects of Apigenin on Steroidogenesis and Steroidogenic Acute Regulatory Gene Expression in Mouse Leydig Cells. J. Nutr. Biochem. 2011, 22, 212–218. [Google Scholar] [CrossRef] [PubMed]
  73. Wang, X.; Shen, C.-L.; Dyson, M.T.; Eimerl, S.; Orly, J.; Hutson, J.C.; Stocco, D.M. Cyclooxygenase-2 Regulation of the Age-Related Decline in Testosterone Biosynthesis. Endocrinology 2005, 146, 4202–4208. [Google Scholar] [CrossRef] [PubMed]
  74. Wang, X.; Wang, G.; Li, X.; Liu, J.; Hong, T.; Zhu, Q.; Huang, P.; Ge, R.-S. Suppression of Rat and Human Androgen Biosynthetic Enzymes by Apigenin: Possible Use for the Treatment of Prostate Cancer. Fitoterapia 2016, 111, 66–72. [Google Scholar] [CrossRef]
  75. Ohlsson, A.; Ullerås, E.; Cedergreen, N.; Oskarsson, A. Mixture Effects of Dietary Flavonoids on Steroid Hormone Synthesis in the Human Adrenocortical H295R Cell Line. Food Chem. Toxicol. 2010, 48, 3194–3200. [Google Scholar] [CrossRef]
  76. Hasegawa, E.; Nakagawa, S.; Sato, M.; Tachikawa, E.; Yamato, S. Effect of Polyphenols on Production of Steroid Hormones from Human Adrenocortical NCI-H295R Cells. Biol. Pharm. Bull. 2013, 36, 228–237. [Google Scholar] [CrossRef] [PubMed]
  77. Wang, X.J. Natural Flavonoids in StAR Gene Expression and Testosterone Biosynthesis in Leydig Cell AgingBasic and Clinical Endocrinology Up-to-Date; InTech: Rijeka, Croatia, 2011. [Google Scholar]
  78. Chen, C.-Y.; Peng, W.-H.; Tsai, K.-D.; Hsu, S.-L. Luteolin Suppresses Inflammation-Associated Gene Expression by Blocking NF-kappaB and AP-1 Activation Pathway in Mouse Alveolar Macrophages. Life Sci. 2007, 81, 1602–1614. [Google Scholar] [CrossRef]
  79. Ha, S.K.; Moon, E.; Kim, S.Y. Chrysin Suppresses LPS-Stimulated Proinflammatory Responses by Blocking NF-κB and JNK Activations in Microglia Cells. Neurosci. Lett. 2010, 485, 143–147. [Google Scholar] [CrossRef]
  80. Jeong, H.J.; Shin, Y.G.; Kim, I.H.; Pezzuto, J.M. Inhibition of Aromatase Activity by Flavonoids. Arch. Pharm. Res. 1999, 22, 309–312. [Google Scholar] [CrossRef]
  81. Kellis, J.T.; Vickery, L.E. Inhibition of Human Estrogen Synthetase (Aromatase) by Flavones. Science 1984, 225, 1032–1034. [Google Scholar] [CrossRef]
  82. Ciftci, O.; Ozdemir, I.; Aydin, M.; Beytur, A. Beneficial Effects of Chrysin on the Reproductive System of Adult Male Rats. Andrologia 2012, 44, 181–186. [Google Scholar] [CrossRef] [PubMed]
  83. Gambelunghe, C.; Rossi, R.; Sommavilla, M.; Ferranti, C.; Rossi, R.; Ciculi, C.; Gizzi, S.; Micheletti, A.; Rufini, S. Effects of Chrysin on Urinary Testosterone Levels in Human Males. J. Med. Food 2003, 6, 387–390. [Google Scholar] [CrossRef] [PubMed]
  84. Del Fabbro, L.; Jesse, C.R.; de Gomes, M.G.; Borges Filho, C.; Donato, F.; Souza, L.C.; Goes, A.R.; Furian, A.F.; Boeira, S.P. The Flavonoid Chrysin Protects against Zearalenone Induced Reproductive Toxicity in Male Mice. Toxicon Off. J. Int. Soc. Toxinol. 2019, 165, 13–21. [Google Scholar] [CrossRef] [PubMed]
  85. Dhawan, K.; Kumar, S.; Sharma, A. Beneficial Effects of Chrysin and Benzoflavone on Virility in 2-Year-Old Male Rats. J. Med. Food 2002, 5, 43–48. [Google Scholar] [CrossRef] [PubMed]
  86. Soltani, M.; Rahmati, M.; Nikravesh, M.R.; Saeedi Nejat, S.; Jalali, M. The Effect of Chrysin on the Distribution of Extracellular Matrix Proteins around Leydig Cells under Heat Stress Injury. J. Food Biochem. 2024, 2024, e9060893. [Google Scholar] [CrossRef]
  87. Abadi, A.R.R.; Boukani, L.M.; Shokoohi, M.; Vaezi, N.; Mahmoodi, M.; Gharekhani, M.; Kouchesfahani, H.M.; Khaki, A.A. The Flavonoid Chrysin Protects against Testicular Apoptosis Induced by Torsion/Detorsion in Adult Rats. Andrologia 2023, 2023, e6500587. [Google Scholar] [CrossRef]
  88. Chen, L.-J.; Games, D.E.; Jones, J. Isolation and Identification of Four Flavonoid Constituents from the Seeds of Oroxylum Indicum by High-Speed Counter-Current Chromatography. J. Chromatogr. A 2003, 988, 95–105. [Google Scholar] [CrossRef]
  89. Nishioka, T.; Kawabata, J.; Aoyama, Y. Baicalein, an Alpha-Glucosidase Inhibitor from Scutellaria Baicalensis. J. Nat. Prod. 1998, 61, 1413–1415. [Google Scholar] [CrossRef]
  90. Wang, W.; Zheng, J.; Cui, N.; Jiang, L.; Zhou, H.; Zhang, D.; Hao, G. Baicalin Ameliorates Polycystic Ovary Syndrome through AMP-Activated Protein Kinase. J. Ovarian Res. 2019, 12, 109. [Google Scholar] [CrossRef]
  91. Carreau, S.; Hess, R.A. Oestrogens and Spermatogenesis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2010, 365, 1517–1535. [Google Scholar] [CrossRef]
  92. Dorrington, J.H.; Armstrong, D.T. Follicle-Stimulating Hormone Stimulates Estradiol-17beta Synthesis in Cultured Sertoli Cells. Proc. Natl. Acad. Sci. USA 1975, 72, 2677–2681. [Google Scholar] [CrossRef] [PubMed]
  93. Hsueh, A.J.; Dufau, M.L.; Catt, K.J. Direct Inhibitory Effect of Estrogen on Leydig Cell Function of Hypophysectomized Rats. Endocrinology 1978, 103, 1096–1102. [Google Scholar] [CrossRef] [PubMed]
  94. Valladares, L.E.; Payne, A.H. Induction of Testicular Aromatization by Luteinizing Hormone in Mature Rats. Endocrinology 1979, 105, 431–436. [Google Scholar] [CrossRef] [PubMed]
  95. Zhu, Y.; Xu, H.; Li, M.; Gao, Z.; Huang, J.; Liu, L.; Huang, X.; Li, Y. Daidzein Impairs Leydig Cell Testosterone Production and Sertoli Cell Function in Neonatal Mouse Testes: An in Vitro Study. Mol. Med. Rep. 2016, 14, 5325–5333. [Google Scholar] [CrossRef]
  96. Chen, Y.-C.; Nagpal, M.L.; Stocco, D.M.; Lin, T. Effects of Genistein, Resveratrol, and Quercetin on Steroidogenesis and Proliferation of MA-10 Mouse Leydig Tumor Cells. J. Endocrinol. 2007, 192, 527–537. [Google Scholar] [CrossRef] [PubMed]
  97. Lehraiki, A.; Chamaillard, C.; Krust, A.; Habert, R.; Levacher, C. Genistein Impairs Early Testosterone Production in Fetal Mouse Testis via Estrogen Receptor Alpha. Toxicol. In Vitro 2011, 25, 1542–1547. [Google Scholar] [CrossRef] [PubMed]
  98. Hu, G.-X.; Zhao, B.-H.; Chu, Y.-H.; Zhou, H.-Y.; Akingbemi, B.T.; Zheng, Z.-Q.; Ge, R.-S. Effects of Genistein and Equol on Human and Rat Testicular 3beta-Hydroxysteroid Dehydrogenase and 17beta-Hydroxysteroid Dehydrogenase 3 Activities. Asian J. Androl. 2010, 12, 519–526. [Google Scholar] [CrossRef]
  99. Le Bail, J.C.; Champavier, Y.; Chulia, A.J.; Habrioux, G. Effects of Phytoestrogens on Aromatase, 3beta and 17beta-Hydroxysteroid Dehydrogenase Activities and Human Breast Cancer Cells. Life Sci. 2000, 66, 1281–1291. [Google Scholar] [CrossRef]
  100. Hamilton-Reeves, J.M.; Vazquez, G.; Duval, S.J.; Phipps, W.R.; Kurzer, M.S.; Messina, M.J. Clinical Studies Show No Effects of Soy Protein or Isoflavones on Reproductive Hormones in Men: Results of a Meta-Analysis. Fertil. Steril. 2010, 94, 997–1007. [Google Scholar] [CrossRef]
  101. Jones, S.; Boisvert, A.; Naghi, A.; Hullin-Matsuda, F.; Greimel, P.; Kobayashi, T.; Papadopoulos, V.; Culty, M. Stimulatory Effects of Combined Endocrine Disruptors on MA-10 Leydig Cell Steroid Production and Lipid Homeostasis. Toxicology 2016, 355–356, 21–30. [Google Scholar] [CrossRef]
  102. Sherrill, J.D.; Sparks, M.; Dennis, J.; Mansour, M.; Kemppainen, B.W.; Bartol, F.F.; Morrison, E.E.; Akingbemi, B.T. Developmental Exposures of Male Rats to Soy Isoflavones Impact Leydig Cell Differentiation. Biol. Reprod. 2010, 83, 488–501. [Google Scholar] [CrossRef] [PubMed]
  103. Strauss, L.; Mäkelä, S.; Joshi, S.; Huhtaniemi, I.; Santti, R. Genistein Exerts Estrogen-like Effects in Male Mouse Reproductive Tract. Mol. Cell. Endocrinol. 1998, 144, 83–93. [Google Scholar] [CrossRef]
  104. Levy, J.R.; Faber, K.A.; Ayyash, L.; Hughes, C.L. The Effect of Prenatal Exposure to the Phytoestrogen Genistein on Sexual Differentiation in Rats. Proc. Soc. Exp. Biol. Med. 1995, 208, 60–66. [Google Scholar] [CrossRef]
  105. Roberts, D.; Veeramachaneni, D.N.; Schlaff, W.D.; Awoniyi, C.A. Effects of Chronic Dietary Exposure to Genistein, a Phytoestrogen, during Various Stages of Development on Reproductive Hormones and Spermatogenesis in Rats. Endocrine 2000, 13, 281–286. [Google Scholar] [CrossRef] [PubMed]
  106. Evans, B.A.; Griffiths, K.; Morton, M.S. Inhibition of 5 Alpha-Reductase in Genital Skin Fibroblasts and Prostate Tissue by Dietary Lignans and Isoflavonoids. J. Endocrinol. 1995, 147, 295–302. [Google Scholar] [CrossRef] [PubMed]
  107. Yi, M.-A.; Son, H.M.; Lee, J.-S.; Kwon, C.-S.; Lim, J.K.; Yeo, Y.K.; Park, Y.S.; Kim, J.-S. Regulation of Male Sex Hormone Levels by Soy Isoflavones in Rats. Nutr. Cancer 2002, 42, 206–210. [Google Scholar] [CrossRef]
  108. Moyad, M.A. Soy, Disease Prevention, and Prostate Cancer. Semin. Urol. Oncol. 1999, 17, 97–102. [Google Scholar]
  109. Ferigolo, M.; Nardi, J.; Freddo, N.; Ferramosca, A.; Zara, V.; Dallegrave, E.; Macedo, M.B.; Eller, S.; de Oliveira, A.P.; Biazus, I.C.; et al. Evaluation of Genistein as a Mitochondrial Modulator and Its Effects on Sperm Quality. Int. J. Mol. Sci. 2023, 24, 14260. [Google Scholar] [CrossRef]
  110. McVey, M.J.; Cooke, G.M.; Curran, I.H.A. Increased Serum and Testicular Androgen Levels in F1 Rats with Lifetime Exposure to Soy Isoflavones. Reprod. Toxicol. 2004, 18, 677–685. [Google Scholar] [CrossRef]
  111. Al-Shaikh, T.M. Role of Soy Isoflavone in Preventing Aging Changes in Rat Testis: Biochemical and Histological Studies. Saudi J. Biol. Sci. 2022, 29, 103423. [Google Scholar] [CrossRef]
  112. Caceres, S.; Crespo, B.; Alonso-Diez, A.; de Andrés, P.J.; Millan, P.; Silván, G.; Illera, M.J.; Illera, J.C. Long-Term Exposure to Isoflavones Alters the Hormonal Steroid Homeostasis-Impairing Reproductive Function in Adult Male Wistar Rats. Nutrients 2023, 15, 1261. [Google Scholar] [CrossRef] [PubMed]
  113. Shi, Z.; Lv, Z.; Hu, C.; Zhang, Q.; Wang, Z.; Hamdard, E.; Dai, H.; Mustafa, S.; Shi, F. Oral Exposure to Genistein during Conception and Lactation Period Affects the Testicular Development of Male Offspring Mice. Animals 2020, 10, 377. [Google Scholar] [CrossRef] [PubMed]
  114. Jeminiwa, B.O.; Knight, R.M.; Braden, T.D.; Cruz-Espindola, C.; Boothe, D.M.; Akingbemi, B.T. Regulation of the Neuroendocrine Axis in Male Rats by Soy-Based Diets Is Independent of Age and Due Specifically to Isoflavone Action†. Biol. Reprod. 2020, 103, 892–906. [Google Scholar] [CrossRef] [PubMed]
  115. Reed, K.E.; Camargo, J.; Hamilton-Reeves, J.; Kurzer, M.; Messina, M. Neither Soy nor Isoflavone Intake Affects Male Reproductive Hormones: An Expanded and Updated Meta-Analysis of Clinical Studies. Reprod. Toxicol. 2021, 100, 60–67. [Google Scholar] [CrossRef] [PubMed]
  116. Scholten, S.D.; Sergeev, I.N.; Song, Q.; Birger, C.B. Effects of Vitamin D and Quercetin, Alone and in Combination, on Cardiorespiratory Fitness and Muscle Function in Physically Active Male Adults. Open Access J. Sports Med. 2015, 6, 229–239. [Google Scholar] [CrossRef] [PubMed]
  117. Samova, S.; Patel, C.N.; Doctor, H.; Pandya, H.A.; Verma, R.J. The Effect of Bisphenol A on Testicular Steroidogenesis and Its Amelioration by Quercetin: An in Vivo and in Silico Approach. Toxicol. Res. 2018, 7, 22–31. [Google Scholar] [CrossRef] [PubMed]
  118. King, S.R.; LaVoie, H.A. Gonadal Transactivation of STARD1, CYP11A1 and HSD3B. Front. Biosci. Landmark Ed. 2012, 17, 824–846. [Google Scholar] [CrossRef]
  119. Manna, P.R.; Dyson, M.T.; Eubank, D.W.; Clark, B.J.; Lalli, E.; Sassone-Corsi, P.; Zeleznik, A.J.; Stocco, D.M. Regulation of Steroidogenesis and the Steroidogenic Acute Regulatory Protein by a Member of the cAMP Response-Element Binding Protein Family. Mol. Endocrinol. 2002, 16, 184–199. [Google Scholar] [CrossRef]
  120. Manna, P.R.; Eubank, D.W.; Lalli, E.; Sassone-Corsi, P.; Stocco, D.M. Transcriptional Regulation of the Mouse Steroidogenic Acute Regulatory Protein Gene by the cAMP Response-Element Binding Protein and Steroidogenic Factor 1. J. Mol. Endocrinol. 2003, 30, 381–397. [Google Scholar] [CrossRef]
  121. Wang, D.; Li, Y.; Zhai, Q.-Q.; Zhu, Y.-F.; Liu, B.-Y.; Xu, Y. Quercetin Ameliorates Testosterone Secretion Disorder by Inhibiting Endoplasmic Reticulum Stress through the miR-1306-5p/HSD17B7 Axis in Diabetic Rats. Bosn. J. Basic Med. Sci. 2022, 22, 191–204. [Google Scholar] [CrossRef]
  122. Abarikwu, S.O.; Farombi, E.O. Quercetin Ameliorates Atrazine-Induced Changes in the Testicular Function of Rats. Toxicol. Ind. Health 2016, 32, 1278–1285. [Google Scholar] [CrossRef] [PubMed]
  123. Ujah, G.A.; Nna, V.U.; Agah, M.I.; Omue, L.O.; Leku, C.B.; Osim, E.E. Effect of Quercetin on Cadmium Chloride-Induced Impairments in Sexual Behaviour and Steroidogenesis in Male Wistar Rats. Andrologia 2018, 50, e12866. [Google Scholar] [CrossRef] [PubMed]
  124. Sun, J.; Wang, D.; Lin, J.; Liu, Y.; Xu, L.; Lv, R.; Mo, K.; Lian, X.; Xie, M.; Xu, S.; et al. Icariin Protects Mouse Leydig Cell Testosterone Synthesis from the Adverse Effects of Di(2-Ethylhexyl) Phthalate. Toxicol. Appl. Pharmacol. 2019, 378, 114612. [Google Scholar] [CrossRef] [PubMed]
  125. Chau, Y.M.; Crawford, P.A.; Woodson, K.G.; Polish, J.A.; Olson, L.M.; Sadovsky, Y. Role of Steroidogenic-Factor 1 in Basal and 3′,5′-Cyclic Adenosine Monophosphate-Mediated Regulation of Cytochrome P450 Side-Chain Cleavage Enzyme in the Mouse. Biol. Reprod. 1997, 57, 765–771. [Google Scholar] [CrossRef] [PubMed]
  126. Smith, O.E.; Morin, F.; Roussel, V.; Bertucci, M.C.; Boyer, A.; Murphy, B.D. The Role of Steroidogenic Factor 1 (SF-1) in Steroidogenic Cell Function of the Testes and Ovaries of Mature Mice. Reproduction 2023, 165, 1–17. [Google Scholar] [CrossRef] [PubMed]
  127. Chen, M.; Hao, J.; Yang, Q.; Li, G. Effects of Icariin on Reproductive Functions in Male Rats. Molecules 2014, 19, 9502–9514. [Google Scholar] [CrossRef] [PubMed]
  128. Ni, G.; Zhang, X.; Afedo, S.Y.; Rui, R. Evaluation of the Protective Effects of Icariin on Nicotine-Induced Reproductive Toxicity in Male Mouse—A Pilot Study. Reprod. Biol. Endocrinol. RBE 2020, 18, 65. [Google Scholar] [CrossRef] [PubMed]
  129. Wang, Q.; Hao, J.; Pu, J.; Zhao, L.; Lü, Z.; Hu, J.; Yu, Q.; Wang, Y.; Xie, Y.; Li, G. Icariin Induces Apoptosis in Mouse MLTC-10 Leydig Tumor Cells through Activation of the Mitochondrial Pathway and down-Regulation of the Expression of Piwil4. Int. J. Oncol. 2011, 39, 973–980. [Google Scholar] [CrossRef] [PubMed]
  130. Elsawy, H.; Badr, G.M.; Sedky, A.; Abdallah, B.M.; Alzahrani, A.M.; Abdel-Moneim, A.M. Rutin Ameliorates Carbon Tetrachloride (CCl4)-Induced Hepatorenal Toxicity and Hypogonadism in Male Rats. PeerJ 2019, 7, e7011. [Google Scholar] [CrossRef]
  131. Abarikwu, S.O.; Iserhienrhien, B.O.; Badejo, T.A. Rutin- and Selenium-Attenuated Cadmium-Induced Testicular Pathophysiology in Rats. Hum. Exp. Toxicol. 2013, 32, 395–406. [Google Scholar] [CrossRef]
  132. Abarikwu, S.O.; Olufemi, P.D.; Lawrence, C.J.; Wekere, F.C.; Ochulor, A.C.; Barikuma, A.M. Rutin, an Antioxidant Flavonoid, Induces Glutathione and Glutathione Peroxidase Activities to Protect against Ethanol Effects in Cadmium-Induced Oxidative Stress in the Testis of Adult Rats. Andrologia 2017, 49, e12696. [Google Scholar] [CrossRef] [PubMed]
  133. AbdElrazek, D.A.; Hassan, N.H.; Ibrahim, M.A.; Hassanen, E.I.; Farroh, K.Y.; Abass, H.I. Ameliorative Effects of Rutin and Rutin-Loaded Chitosan Nanoparticles on Testicular Oxidative Stress and Histological Damage Induced by Cyclophosphamide in Male Rats. Food Chem. Toxicol. 2024, 184, 114436. [Google Scholar] [CrossRef] [PubMed]
  134. Fei, Q.; Li, X.; Zhu, Q.; Wang, Y.; Ge, R.; Jin, X. Rutin Inhibits Androgen Synthesis and Metabolism in Rat Immature Leydig Cells in Vitro. Andrologia 2021, 53, e14221. [Google Scholar] [CrossRef] [PubMed]
  135. Ge, F.; Tian, E.; Wang, L.; Li, X.; Zhu, Q.; Wang, Y.; Zhong, Y.; Ge, R.-S. Taxifolin Suppresses Rat and Human Testicular Androgen Biosynthetic Enzymes. Fitoterapia 2018, 125, 258–265. [Google Scholar] [CrossRef] [PubMed]
  136. Papiez, M.A. Influence of Naringenin on the Activity of Enzymes Participating in Steroidogenesis in Male Rats. Rocz. Akad. Med. W Bialymstoku 1995 2004, 49 (Suppl. S1), 120–122. [Google Scholar]
  137. Adana, M.Y.; Akang, E.N.; Naidu, E.C.S.; Aniekan, P.I.; Kouame, K.; Offor, U.; Ogedengbe, O.O.; Azu, O.O. Testicular Microanatomical and Hormonal Alterations Following Use of Antiretroviral Therapy in Sprague Dawley Rats: Role of Naringenin. Andrologia 2018, 50, e13137. [Google Scholar] [CrossRef] [PubMed]
  138. Fouad, A.A.; Refaie, M.M.M.; Abdelghany, M.I. Naringenin Palliates Cisplatin and Doxorubicin Gonadal Toxicity in Male Rats. Toxicol. Mech. Methods 2019, 29, 67–73. [Google Scholar] [CrossRef] [PubMed]
  139. Wang, J.; Zhu, H.; Lin, S.; Wang, K.; Wang, H.; Liu, Z. Protective Effect of Naringenin against Cadmium-Induced Testicular Toxicity in Male SD Rats. J. Inorg. Biochem. 2021, 214, 111310. [Google Scholar] [CrossRef] [PubMed]
  140. Alboghobeish, S.; Mahdavinia, M.; Zeidooni, L.; Samimi, A.; Oroojan, A.A.; Alizadeh, S.; Dehghani, M.A.; Ahangarpour, A.; Khorsandi, L. Efficiency of Naringin against Reproductive Toxicity and Testicular Damages Induced by Bisphenol A in Rats. Iran. J. Basic Med. Sci. 2019, 22, 315–523. [Google Scholar] [CrossRef]
  141. Okesina, K.B.; Odetayo, A.F.; Adeyemi, W.J.; Ajibare, A.J.; Okesina, A.A.; Olayaki, L.A. Naringin from Sweet Orange Peel Improves Testicular Function in High Fat Diet-Induced Diabetic Rats by Modulating Xanthine Oxidase/Uric Acid Signaling and Maintaining Redox Balance. Lab. Anim. Res. 2024, 40, 5. [Google Scholar] [CrossRef]
  142. Samie, A.; Sedaghat, R.; Baluchnejadmojarad, T.; Roghani, M. Hesperetin, a Citrus Flavonoid, Attenuates Testicular Damage in Diabetic Rats via Inhibition of Oxidative Stress, Inflammation, and Apoptosis. Life Sci. 2018, 210, 132–139. [Google Scholar] [CrossRef] [PubMed]
  143. Helmy, H.S.; Senousy, M.A.; El-Sahar, A.E.; Sayed, R.H.; Saad, M.A.; Elbaz, E.M. Aberrations of miR-126-3p, miR-181a and Sirtuin1 Network Mediate Di-(2-Ethylhexyl) Phthalate-Induced Testicular Damage in Rats: The Protective Role of Hesperidin. Toxicology 2020, 433–434, 152406. [Google Scholar] [CrossRef] [PubMed]
  144. Vijaya Bharathi, B.; Jaya Prakash, G.; Krishna, K.M.; Ravi Krishna, C.H.; Sivanarayana, T.; Madan, K.; Rama Raju, G.A.; Annapurna, A. Protective Effect of Alpha Glucosyl Hesperidin (G-Hesperidin) on Chronic Vanadium Induced Testicular Toxicity and Sperm Nuclear DNA Damage in Male Sprague Dawley Rats. Andrologia 2015, 47, 568–578. [Google Scholar] [CrossRef] [PubMed]
  145. Yu, P.-L.; Pu, H.-F.; Chen, S.-Y.; Wang, S.-W.; Wang, P.S. Effects of Catechin, Epicatechin and Epigallocatechin Gallate on Testosterone Production in Rat Leydig Cells. J. Cell. Biochem. 2010, 110, 333–342. [Google Scholar] [CrossRef] [PubMed]
  146. Figueiroa, M.S.; César Vieira, J.S.B.; Leite, D.S.; Filho, R.C.O.A.; Ferreira, F.; Gouveia, P.S.; Udrisar, D.P.; Wanderley, M.I. Green Tea Polyphenols Inhibit Testosterone Production in Rat Leydig Cells. Asian J. Androl. 2009, 11, 362–370. [Google Scholar] [CrossRef] [PubMed]
  147. Monteiro, R.; Assunção, M.; Andrade, J.P.; Neves, D.; Calhau, C.; Azevedo, I. Chronic Green Tea Consumption Decreases Body Mass, Induces Aromatase Expression, and Changes Proliferation and Apoptosis in Adult Male Rat Adipose Tissue. J. Nutr. 2008, 138, 2156–2163. [Google Scholar] [CrossRef] [PubMed]
  148. Satoh, K.; Sakamoto, Y.; Ogata, A.; Nagai, F.; Mikuriya, H.; Numazawa, M.; Yamada, K.; Aoki, N. Inhibition of Aromatase Activity by Green Tea Extract Catechins and Their Endocrinological Effects of Oral Administration in Rats. Food Chem. Toxicol. 2002, 40, 925–933. [Google Scholar] [CrossRef] [PubMed]
  149. Basini, G.; Bianco, F.; Grasselli, F. Epigallocatechin-3-Gallate from Green Tea Negatively Affects Swine Granulosa Cell Function. Domest. Anim. Endocrinol. 2005, 28, 243–256. [Google Scholar] [CrossRef] [PubMed]
  150. Khoo, H.E.; Azlan, A.; Tang, S.T.; Lim, S.M. Anthocyanidins and Anthocyanins: Colored Pigments as Food, Pharmaceutical Ingredients, and the Potential Health Benefits. Food Nutr. Res. 2017, 61, 1361779. [Google Scholar] [CrossRef]
  151. He, Y.; Hu, Y.; Jiang, X.; Chen, T.; Ma, Y.; Wu, S.; Sun, J.; Jiao, R.; Li, X.; Deng, L.; et al. Cyanidin-3-O-Glucoside Inhibits the UVB-Induced ROS/COX-2 Pathway in HaCaT Cells. J. Photochem. Photobiol. B 2017, 177, 24–31. [Google Scholar] [CrossRef]
  152. Ma, M.-M.; Li, Y.; Liu, X.-Y.; Zhu, W.-W.; Ren, X.; Kong, G.-Q.; Huang, X.; Wang, L.-P.; Luo, L.-Q.; Wang, X.-Z. Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways. Inflammation 2015, 38, 1669–1682. [Google Scholar] [CrossRef] [PubMed]
  153. Wen, L.; Jiang, X.; Sun, J.; Li, X.; Li, X.; Tian, L.; Li, Y.; Bai, W. Cyanidin-3-O-Glucoside Promotes the Biosynthesis of Progesterone through the Protection of Mitochondrial Function in Pb-Exposed Rat Leydig Cells. Food Chem. Toxicol. 2018, 112, 427–434. [Google Scholar] [CrossRef] [PubMed]
  154. Li, X.; Guo, J.; Jiang, X.; Sun, J.; Tian, L.; Jiao, R.; Tang, Y.; Bai, W. Cyanidin-3-O-Glucoside Protects against Cadmium-Induced Dysfunction of Sex Hormone Secretion via the Regulation of Hypothalamus-Pituitary-Gonadal Axis in Male Pubertal Mice. Food Chem. Toxicol. 2019, 129, 13–21. [Google Scholar] [CrossRef] [PubMed]
  155. Mandal, S.M.; Chakraborty, D.; Dey, S. Phenolic Acids Act as Signaling Molecules in Plant-Microbe Symbioses. Plant Signal. Behav. 2010, 5, 359–368. [Google Scholar] [CrossRef] [PubMed]
  156. Erboga, M.; Kanter, M.; Aktas, C.; Bozdemir Donmez, Y.; Fidanol Erboga, Z.; Aktas, E.; Gurel, A. Anti-Apoptotic and Anti-Oxidant Effects of Caffeic Acid Phenethyl Ester on Cadmium-Induced Testicular Toxicity in Rats. Biol. Trace Elem. Res. 2016, 171, 176–184. [Google Scholar] [CrossRef] [PubMed]
  157. Hu, G.-X.; Liang, G.; Chu, Y.; Li, X.; Lian, Q.-Q.; Lin, H.; He, Y.; Huang, Y.; Hardy, D.O.; Ge, R.-S. Curcumin Derivatives Inhibit Testicular 17beta-Hydroxysteroid Dehydrogenase 3. Bioorg. Med. Chem. Lett. 2010, 20, 2549–2551. [Google Scholar] [CrossRef] [PubMed]
  158. Lin, Y.-C.; Chiu, C.-H.; Liu, H.-C.; Wang, J.-Y. Curcumin Downregulates 8-Br-cAMP-Induced Steroidogenesis in Mouse Leydig Cells by Suppressing the Expression of Cyp11a1 and StAR Independently of the PKA-CREB Pathway. Endocr. J. 2018, 65, 833–840. [Google Scholar] [CrossRef] [PubMed]
  159. Langcake, P.; Pryce, R.J. The Production of Resveratrol by Vitis Vinifera and Other Members of the Vitaceae as a Response to Infection or Injury. Physiol. Plant Pathol. 1976, 9, 77–86. [Google Scholar] [CrossRef]
  160. Gambini, J.; Inglés, M.; Olaso, G.; Lopez-Grueso, R.; Bonet-Costa, V.; Gimeno-Mallench, L.; Mas-Bargues, C.; Abdelaziz, K.M.; Gomez-Cabrera, M.C.; Vina, J.; et al. Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans. Oxid. Med. Cell. Longev. 2015, 2015, 837042. [Google Scholar] [CrossRef]
  161. Pasquariello, R.; Verdile, N.; Brevini, T.A.L.; Gandolfi, F.; Boiti, C.; Zerani, M.; Maranesi, M. The Role of Resveratrol in Mammalian Reproduction. Molecules 2020, 25, 4554. [Google Scholar] [CrossRef]
  162. Mongioì, L.M.; Perelli, S.; Condorelli, R.A.; Barbagallo, F.; Crafa, A.; Cannarella, R.; La Vignera, S.; Calogero, A.E. The Role of Resveratrol in Human Male Fertility. Molecules 2021, 26, 2495. [Google Scholar] [CrossRef] [PubMed]
  163. Li, L.; Chen, X.; Zhu, Q.; Chen, D.; Guo, J.; Yao, W.; Dong, Y.; Wei, J.; Lian, Q.; Ge, R.-S.; et al. Disrupting Androgen Production of Leydig Cells by Resveratrol via Direct Inhibition of Human and Rat 3β-Hydroxysteroid Dehydrogenase. Toxicol. Lett. 2014, 226, 14–19. [Google Scholar] [CrossRef] [PubMed]
  164. Svechnikov, K.; Spatafora, C.; Svechnikova, I.; Tringali, C.; Söder, O. Effects of Resveratrol Analogs on Steroidogenesis and Mitochondrial Function in Rat Leydig Cells in Vitro. J. Appl. Toxicol. JAT 2009, 29, 673–680. [Google Scholar] [CrossRef] [PubMed]
  165. Price, N.L.; Gomes, A.P.; Ling, A.J.Y.; Duarte, F.V.; Martin-Montalvo, A.; North, B.J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J.S.; et al. SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function. Cell Metab. 2012, 15, 675–690. [Google Scholar] [CrossRef] [PubMed]
  166. Abdou, H.S.; Bergeron, F.; Tremblay, J.J. A Cell-Autonomous Molecular Cascade Initiated by AMP-Activated Protein Kinase Represses Steroidogenesis. Mol. Cell. Biol. 2014, 34, 4257–4271. [Google Scholar] [CrossRef] [PubMed]
  167. Wang, H.-J.; Wang, Q.; Lv, Z.-M.; Wang, C.-L.; Li, C.-P.; Rong, Y.-L. Resveratrol Appears to Protect against Oxidative Stress and Steroidogenesis Collapse in Mice Fed High-Calorie and High-Cholesterol Diet. Andrologia 2015, 47, 59–65. [Google Scholar] [CrossRef] [PubMed]
  168. Lin, F.; Zhang, S.; Zhu, X.; Lv, Z. Autophagy-Related 7 Proteindependent Autophagy Mediates Resveratrol-Caused Upregulation of Mitochondrial Biogenesis and Steroidogenesis in Aged Leydig Cell. Mol. Biol. Rep. 2023, 51, 28. [Google Scholar] [CrossRef] [PubMed]
  169. Greifová, H.; Jambor, T.; Tokárová, K.; Speváková, I.; Knížatová, N.; Lukáč, N. Resveratrol Attenuates Hydrogen Peroxide-Induced Oxidative Stress in TM3 Leydig Cells in Vitro. J. Environ. Sci. Health Part A Toxic/Hazard. Subst. Environ. Eng. 2020, 55, 585–595. [Google Scholar] [CrossRef]
  170. Liu, S.; Sun, Y.; Li, Z. Resveratrol Protects Leydig Cells from Nicotine-Induced Oxidative Damage through Enhanced Autophagy. Clin. Exp. Pharmacol. Physiol. 2018, 45, 573–580. [Google Scholar] [CrossRef]
  171. Jambor, T.; Zajickova, T.; Arvay, J.; Ivanisova, E.; Tirdilova, I.; Knizatova, N.; Greifova, H.; Kovacik, A.; Galova, E.; Lukac, N. Exceptional Properties of Lepidium sativum L. Extract and Its Impact on Cell Viability, Ros Production, Steroidogenesis, and Intracellular Communication in Mice Leydig Cells In Vitro. Molecules 2022, 27, 5127. [Google Scholar] [CrossRef]
  172. Bellavite, P. Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action. Antioxidants 2023, 12, 280. [Google Scholar] [CrossRef] [PubMed]
  173. Hashem, N.M.; Gonzalez-Bulnes, A.; Simal-Gandara, J. Polyphenols in Farm Animals: Source of Reproductive Gain or Waste? Antioxidants 2020, 9, 1023. [Google Scholar] [CrossRef] [PubMed]
  174. Samodien, E.; Johnson, R.; Pheiffer, C.; Mabasa, L.; Erasmus, M.; Louw, J.; Chellan, N. Diet-Induced Hypothalamic Dysfunction and Metabolic Disease, and the Therapeutic Potential of Polyphenols. Mol. Metab. 2019, 27, 1–10. [Google Scholar] [CrossRef] [PubMed]
  175. Xiong, J.; Tian, Y.; Ling, A.; Liu, Z.; Zhao, L.; Cheng, G. Genistein Affects Gonadotrophin-Releasing Hormone Secretion in GT1-7 Cells via Modulating Kisspeptin Receptor and Key Regulators. Syst. Biol. Reprod. Med. 2022, 68, 138–150. [Google Scholar] [CrossRef] [PubMed]
  176. Sakakibara, H.; Shimoi, K. Anti-Stress Effects of Polyphenols: Animal Models and Human Trials. Food Funct. 2020, 11, 5702–5717. [Google Scholar] [CrossRef]
  177. Pizarro Meléndez, G.P.; Valero-Jara, V.; Acevedo-Hernández, P.; Thomas-Valdés, S. Impact of Polyphenols on Stress and Anxiety: A Systematic Review of Molecular Mechanisms and Clinical Evidence. Crit. Rev. Food Sci. Nutr. 2024, 64, 2340–2357. [Google Scholar] [CrossRef] [PubMed]
  178. Tsang, C.; Hodgson, L.; Bussu, A.; Farhat, G.; Al-Dujaili, E. Effect of Polyphenol-Rich Dark Chocolate on Salivary Cortisol and Mood in Adults. Antioxidants 2019, 8, 149. [Google Scholar] [CrossRef] [PubMed]
  179. Martin, L.J.; Tremblay, J.J. Glucocorticoids Antagonize cAMP-Induced Star Transcription in Leydig Cells through the Orphan Nuclear Receptor NR4A1. J. Mol. Endocrinol. 2008, 41, 165–175. [Google Scholar] [CrossRef] [PubMed]
  180. Kao, Y.H.; Hiipakka, R.A.; Liao, S. Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin Gallate. Endocrinology 2000, 141, 980–987. [Google Scholar] [CrossRef]
  181. McGarvey, C.; Cates, P.A.; Brooks, A.; Swanson, I.A.; Milligan, S.R.; Coen, C.W.; O’Byrne, K.T. Phytoestrogens and Gonadotropin-Releasing Hormone Pulse Generator Activity and Pituitary Luteinizing Hormone Release in the Rat. Endocrinology 2001, 142, 1202–1208. [Google Scholar] [CrossRef]
  182. Chupradit, S.; Bokov, D.; Zamanian, M.Y.; Heidari, M.; Hakimizadeh, E. Hepatoprotective and Therapeutic Effects of Resveratrol: A Focus on Anti-Inflammatory and Antioxidative Activities. Fundam. Clin. Pharmacol. 2022, 36, 468–485. [Google Scholar] [CrossRef] [PubMed]
  183. Faghihzadeh, F.; Hekmatdoost, A.; Adibi, P. Resveratrol and Liver: A Systematic Review. J. Res. Med. Sci. 2015, 20, 797–810. [Google Scholar] [CrossRef] [PubMed]
  184. Kasdallah-Grissa, A.; Mornagui, B.; Aouani, E.; Hammami, M.; El May, M.; Gharbi, N.; Kamoun, A.; El-Fazaâ, S. Resveratrol, a Red Wine Polyphenol, Attenuates Ethanol-Induced Oxidative Stress in Rat Liver. Life Sci. 2007, 80, 1033–1039. [Google Scholar] [CrossRef] [PubMed]
  185. Chan, C.-C.; Lee, K.-C.; Huang, Y.-H.; Chou, C.-K.; Lin, H.-C.; Lee, F.-Y. Regulation by Resveratrol of the Cellular Factors Mediating Liver Damage and Regeneration after Acute Toxic Liver Injury. J. Gastroenterol. Hepatol. 2014, 29, 603–613. [Google Scholar] [CrossRef] [PubMed]
  186. de Moraes, A.C.N.; de Andrade, C.B.V.; Ramos, I.P.R.; Dias, M.L.; Batista, C.M.P.; Pimentel, C.F.; de Carvalho, J.J.; Goldenberg, R.C.D.S. Resveratrol Promotes Liver Regeneration in Drug-Induced Liver Disease in Mice. Food Res. Int. 2021, 142, 110185. [Google Scholar] [CrossRef] [PubMed]
  187. Vázquez-Flores, L.F.; Casas-Grajales, S.; Hernández-Aquino, E.; Vargas-Pozada, E.E.; Muriel, P. Antioxidant, Antiinflammatory, and Antifibrotic Properties of Quercetin in the Liver. In Liver Pathophysiology; Elsevier: Amsterdam, The Netherlands, 2017; pp. 653–674. [Google Scholar]
  188. Miltonprabu, S.; Tomczyk, M.; Skalicka-Woźniak, K.; Rastrelli, L.; Daglia, M.; Nabavi, S.F.; Alavian, S.M.; Nabavi, S.M. Hepatoprotective Effect of Quercetin: From Chemistry to Medicine. Food Chem. Toxicol. 2017, 108, 365–374. [Google Scholar] [CrossRef] [PubMed]
  189. Chen, X. Protective Effects of Quercetin on Liver Injury Induced by Ethanol. Pharmacogn. Mag. 2010, 6, 135–141. [Google Scholar] [CrossRef] [PubMed]
  190. Pingili, R.B.; Challa, S.R.; Pawar, A.K.; Toleti, V.; Kodali, T.; Koppula, S. A Systematic Review on Hepatoprotective Activity of Quercetin against Various Drugs and Toxic Agents: Evidence from Preclinical Studies. Phytother. Res. PTR 2020, 34, 5–32. [Google Scholar] [CrossRef]
  191. Tipoe, G.L.; Leung, T.M.; Liong, E.C.; Lau, T.Y.H.; Fung, M.L.; Nanji, A.A. Epigallocatechin-3-Gallate (EGCG) Reduces Liver Inflammation, Oxidative Stress and Fibrosis in Carbon Tetrachloride (CCl4)-Induced Liver Injury in Mice. Toxicology 2010, 273, 45–52. [Google Scholar] [CrossRef]
  192. Tang, G.; Xu, Y.; Zhang, C.; Wang, N.; Li, H.; Feng, Y. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. Antioxidants 2021, 10, 1076. [Google Scholar] [CrossRef]
  193. Rivera-Espinoza, Y.; Muriel, P. Pharmacological Actions of Curcumin in Liver Diseases or Damage. Liver Int. Off. J. Int. Assoc. Study Liver 2009, 29, 1457–1466. [Google Scholar] [CrossRef] [PubMed]
  194. Farzaei, M.H.; Zobeiri, M.; Parvizi, F.; El-Senduny, F.F.; Marmouzi, I.; Coy-Barrera, E.; Naseri, R.; Nabavi, S.M.; Rahimi, R.; Abdollahi, M. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients 2018, 10, 855. [Google Scholar] [CrossRef] [PubMed]
  195. Yue, S.; Xue, N.; Li, H.; Huang, B.; Chen, Z.; Wang, X. Hepatoprotective Effect of Apigenin Against Liver Injury via the Non-Canonical NF-κB Pathway In Vivo and In Vitro. Inflammation 2020, 43, 1634–1648. [Google Scholar] [CrossRef] [PubMed]
  196. Al-Amarat, W.; Abukhalil, M.H.; Alruhaimi, R.S.; Alqhtani, H.A.; Aldawood, N.; Alfwuaires, M.A.; Althunibat, O.Y.; Aladaileh, S.H.; Algefare, A.I.; Alanezi, A.A.; et al. Upregulation of Nrf2/HO-1 Signaling and Attenuation of Oxidative Stress, Inflammation, and Cell Death Mediate the Protective Effect of Apigenin against Cyclophosphamide Hepatotoxicity. Metabolites 2022, 12, 648. [Google Scholar] [CrossRef]
  197. Longcope, C.; Feldman, H.A.; McKinlay, J.B.; Araujo, A.B. Diet and Sex Hormone-Binding Globulin. J. Clin. Endocrinol. Metab. 2000, 85, 293–296. [Google Scholar] [CrossRef]
Figure 1. Common synthesis pathway for testosterone from cholesterol and its subsequent conversion into estrogenic and androgenic active metabolites. Abbreviations for enzymes: CYP11A1, P450 side chain cleavage; HSD3B1, 3β-hydroxysteroid dehydrogenase; CYP17A1, P450 17α-hydroxylase/20-lyase; HSD17B3, 17β-hydroxysteroid dehydrogenase; SRD5A1, 5α-reductase; CYP19A1, P450 aromatase. Abbreviations for steroids: DHEA, dehydroepiandrosterone; DHT, dihydrotestosterone.
Figure 1. Common synthesis pathway for testosterone from cholesterol and its subsequent conversion into estrogenic and androgenic active metabolites. Abbreviations for enzymes: CYP11A1, P450 side chain cleavage; HSD3B1, 3β-hydroxysteroid dehydrogenase; CYP17A1, P450 17α-hydroxylase/20-lyase; HSD17B3, 17β-hydroxysteroid dehydrogenase; SRD5A1, 5α-reductase; CYP19A1, P450 aromatase. Abbreviations for steroids: DHEA, dehydroepiandrosterone; DHT, dihydrotestosterone.
Nutrients 16 01815 g001
Figure 2. Structures of important flavonoids found in plants.
Figure 2. Structures of important flavonoids found in plants.
Nutrients 16 01815 g002
Figure 3. Structures of sinapic, ferulic, iso-ferulic, and caffeic acid phenethyl esters.
Figure 3. Structures of sinapic, ferulic, iso-ferulic, and caffeic acid phenethyl esters.
Nutrients 16 01815 g003
Figure 4. Structures of resveratrol and gigantol.
Figure 4. Structures of resveratrol and gigantol.
Nutrients 16 01815 g004
Figure 5. Summary of the mechanisms of action of natural polyphenolic compounds on testosterone production from Leydig cells of the testis. Flavonoids, isoflavonoids, resveratrol and gigantol mainly regulate steroidogenesis through the modulation of the expression of the Star gene. Dotted lines represent unknown intermediate steps in the regulatory mechanisms. Green arrows correspond to stimulation, red arrows to inhibition, and gray arrows to stimulation or inhibition, depending on context. The blue arrows correspond to improvement of mitochondrial function.
Figure 5. Summary of the mechanisms of action of natural polyphenolic compounds on testosterone production from Leydig cells of the testis. Flavonoids, isoflavonoids, resveratrol and gigantol mainly regulate steroidogenesis through the modulation of the expression of the Star gene. Dotted lines represent unknown intermediate steps in the regulatory mechanisms. Green arrows correspond to stimulation, red arrows to inhibition, and gray arrows to stimulation or inhibition, depending on context. The blue arrows correspond to improvement of mitochondrial function.
Nutrients 16 01815 g005
Table 1. Summary of the important functions of testosterone in males.
Table 1. Summary of the important functions of testosterone in males.
FunctionDescriptionReferences
Development of male reproductive tissuesPromotes the development of the testes, of epididymides and seminal vesicles, of the prostate, as well as of the penis and scrotum[43,44,45,46,47]
Secondary sexual characteristicsResponsible for features such as increased muscle and bone mass, deepening of the voice, and growth of body hair[48,49,50,51]
Adult male fertilityCritical for the initiation and maintenance of spermatogenesis[52]
Involved in the feedback regulation of pituitary gonadotropin production and secretion[53]
Muscle mass and strengthEnhances muscle growth, increases protein synthesis, and improves physical strength[48,54]
Bone growth and densityIncreases bone density and helps maintaining bone health[49,55]
Enhances bone growth during puberty and cessation of growth of long bones at the end of puberty[56,57]
Red blood cell productionStimulates the production of red blood cells in the bone marrow[58]
Mood and mental healthAffects mood, energy levels, and overall sense of well-being; low levels can lead to depression and fatigue[59,60,61,62]
Libido and sexual functionPlays a critical role in sex drive and erectile function[63,64]
Fat distributionInfluences the distribution of body fat, often leading to a reduction in fat mass[65]
Cognitive functionContributes to cognitive functions such as memory and spatial abilities[38,39]
Hair growthPromotes hair growth on the face and body, while potentially contributing to scalp hair loss[51]
Table 2. Lipophilicity of flavonoids basic skeleton.
Table 2. Lipophilicity of flavonoids basic skeleton.
Basic SkeletonLipophilicity (Log p) *
Flavanoids3.47
Flavones/Isoflavones3.18
Flavonols2.84
Flavanones3.18
(+)-Catechin (R = H)0.58
Anthocyanidins2.22
* SwissADME [69].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Martin, L.J.; Touaibia, M. Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants. Nutrients 2024, 16, 1815. https://doi.org/10.3390/nu16121815

AMA Style

Martin LJ, Touaibia M. Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants. Nutrients. 2024; 16(12):1815. https://doi.org/10.3390/nu16121815

Chicago/Turabian Style

Martin, Luc J., and Mohamed Touaibia. 2024. "Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants" Nutrients 16, no. 12: 1815. https://doi.org/10.3390/nu16121815

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop